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1.1 Oral and Periodontal diseases  
 The primary health problems worldwide continue to be a result of chronic diseases with oral 
ailments (Petersen et al., 2005; Petersen and Ogawa, 2012). Therefore, periodontal diseases are 
among the most important global oral health problems (Petersen et al., 2003). Periodontal diseases 
are a combination of periodontal tissue disorders by microorganisms that adhere to and grow on 
the teeth surfaces (dental plaque). Together with an over-aggressive immune response against them, 
they are commonly believed to be the causes of periodontitis. The inflammation refers to the 
pathologic state of the gingival and the supporting structures of the periodontium, which include 
gingival, alveolar bone, periodontal ligament, and cementum. They are commonly found in most 
human populations and result in significant morbidity and loss of the teeth in severe conditions. 
The Periodontal diseases are commonly having two main groups (Fig.1.1), a group of gingival 
diseases, and another group is periodontitis (Wiebe and Putnins, 2000). The inflammation of the 
gingival tissues caused by the accumulation of dental plaque followed by redness, swelling, and 
bleeding of the tissues, which clinically characterized as gingival disease. Gingivitis will not 
progress to periodontitis unless there is perturbation in the local conditions or generalized host 
susceptibility (Offenbacher, 1996). 
 On the other hand, periodontitis is clinically known by the formation of a periodontal pocket, 
which is the leading cause of that soreness. This pocket is an ideal surface for further bacterial 
colonization and the formation of subgingival plaque. The irreversible plaque-induced 
inflammation of the periodontal tissues leads to the destruction of the periodontal ligament and 
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alveolar bone and the migration of the epithelial ligament and teeth losses (Palombo, 2008; 
Williams et al., 1922). The crucial of periodicities diseases is in line with the results of a numerous 
of recent studies that are linking between chronic periodontitis conditions and systemic diseases 
such as diabetes mellitus, AIDS, leukemia, Down's syndrome (Komatsu, 2014; Mehta, 2015), 
cardiovascular diseases (e.g., heart attack, coronary artery disease, and stroke) (Saremi et al., 2005; 









1.2 Oral microorganisms 
 The atmosphere of the oral cavity surface with saliva and a slight temperature range from 34 to 
36◦C, and nearby neutral pH is a suitable environment for most microorganisms (Marcotte and 
Lavoie, 1998; Parahitiyawa et al., 2010). Various analytical approaches illustrated that there are 
more than 700 species with no less than six billion bacteria believed to be the bacterial community 
of the human mouth (Theilade, 1990; Aas et al., 2005), along with fungi, mycoplasma, protozoa, 
and even viruses (Pennisi, 2005). Generally, oral bacteria can be classified as gram-positive and 
gram-negative bacteria, or more specific, and according to their oxygen requirements into 
anaerobic or facultatively anaerobic. The primary isolated microorganisms from the human oral 
cavity are listed in Fig.1.2.  
 Although the diversity of the oral microbiota community, it is well known that oral microbiota 
and the oral cavity are a stable community known as the climax community. Hence, an imbalance 
of oral microbiota leads to the occurrence of oral diseases such as caries and periodontal diseases, 
resulting in the multiplication of possibly pathogenic microorganisms. Numerous studies have 
pointed out the correlation between destruction of periodontal tissue, teeth loss in severe conditions, 
and the changes of microbial species in the gingival sulcus from gram-positive, facultative, 
fermentative microorganisms to predominantly gram-negative, anaerobic, chemoorganotrophic, 
and proteolytic organisms (Eloe-FadroshandRasko, 2013). Therefore, periodontal breakdown 
occurs as a result of multifaceted interactions between bacterial microbiota and the host defense 
mechanisms, leading to the disruption of the balance between bacterial aggression and the host 
protection system (Hajishengallis et al., 2012). Based on this fact, several studies have confirmed 
that the primary etiological agents of periodontal diseases are generally gram-negative rods, which 
include Actinobacillus actinomycetemcomitans, Tannerella forsythia, Prevotella, Fusobacterium, 
4 
 
and Porphyromonas gingivalis. These microbial species are not capable of causing destructive 
events individually. However, to be involved in the periodontal disease progression nonetheless, 
the etiology requires several steps of interaction between these microbial members with other 
surrounding factors to establish their positions in the oral cavity (Marcotte and Lavoie, 1998; 











1.3 Porphyromonas gingivalis 
 Although uncountable bacterial species usually exist in the human oral mucosa microbiota, 
Porphyromonas gingivalis appears to be the primary etiological agent in the pathogenesis and 
progression of the inflammatory events of periodontal disease (Hajishengallis et al., 2012). More 
than 85% of the subgingival plaques of patients with chronic periodontitis have been infected with 
this bacterium (Datta et al., 2008). P. gingivalis was firstly discovered in 1921 (Oliver and Wherry, 
1921) and named Bacterium melaninogenicum, then reclassified in long series to be named as 
Bacteroides gingivalis, until its recent reclassification (Fig.1.3) as a new genus of Porphyromonas 
(Nisengard and Newman, 1994). This bacterium (Fig.1.4) is a non-motile, non-spore forming 
asaccharolytic, gram-negative bacterium, an obligately anaerobic rod, forms black-pigmented 
colonies on blood agar medium, and most of the strains require iron and vitamin K for growth 
(Olczak et al., 2005; Hunt et al., 1986). Iron uptake by this bacterium in the form of heme has been 
proven to play an essential role in its growth and virulence. Nonetheless, unlike many other 
microorganisms, P. gingivalis does not possess a siderophore scavenging system for iron uptake 
or the enzymes required for heme biosynthesis. Instead, it employs alternative mechanisms 
through degrading the iron-transporting plasma proteins albumin, hemopexin, haptoglobin and 
transferrin to obtain iron from host heme (Gao, et al., 2010; Smalley et al., 2011). Various 
investigations revealed that the infection is either iron-limited or severely restricted by the 
availability of iron. Therefore, the virulence of a microorganism is greatly increased with its ability 
to contest with the host for iron. A study conducted by McKee et al. (1986), revealed that the 
virulence of P. gingivalis could be controlled by the level of protoheme added to the culture 
medium. Moreover, iron regulation of the expression of outer membrane proteins since they 
observed the induction of 10 surface proteins when P. gingivalis was grown in hemin restricted 
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conditions hypothesized the involvement of the iron-regulated proteins in hemin uptake and 
virulence of P. gingivalis. (Bramanti and Holt, 1990). 
 Outer cell membrane receptors, proteases (mainly gingipains), lipoproteins, and other specific 
proteins are involved in iron/heme capturing (Olczak et al., 2005). Recent studies strongly 
hypothesized that P. gingivalis interact with other host-microbiota members by producing various 
pathogenic factors, leading to the disease progression. The initiation and development of 
periodontal tissue destruction are complex processes involving plaque accumulation, release of 
bacterial substances, and host inflammatory response.  P. gingivalis produces several virulence 
factors that could penetrate the gingival and destruct the host tissue directly or indirectly by 
induction of inflammation (Pennisi, 2005). 
 Virulence factors are constituents or metabolites of an organism that are crucial in various 
stages of the life cycle and cause damage to the host and produce substances that could initiate 
tissue destruction. The most potent adhesins and virulence factors of P. gingivalis are fimbriae, 
lipopolysaccharides, proteases (gingipains), and potential adhesion molecules such as 
hemagglutinins (Connolly et al., 2017). This pathogenicity factors are playing a vital role in the 
infection process by allowing P. gingivalis to adhere to the surface of host cells. This process 
facilitates the acquisition of heme through erythrocyte binding. It causes lysis and aggregation of 
erythrocytes via several proteolytic enzymes known as gingipains, which release the heme moiety 




Fig.1.3 Evolution of P. gingivalis taxonomy  
 
1.4 The virulence factors 
 P. gingivalis manifests numerous virulence factors associated with periodontal disease 


















Bacterium melaninogenicum (Oliver and Wherry, 1921) 
Hemophilus melaninogenicus (Bergey et al., 1930)  
Ristella melaninogenica (Prévot, 1938) 
Bacteroides melaninogenicus (Roy and Kelly, 1939)  
Fusiformis nigrescens (Schwabacher et al., 1947)  
Bacteroides melaninogenicus (Kelly, 1957)  
Bacteroides melaninogenicus subsp. asaccharolyticus (Holdeman and Moore, 1970) 
Bacteroides asaccharolyticus (Finegold and Barnes, 1984) 
Bacteroides gingivalis (42)  
Bacteroides asaccharolyticus 
(Finegold and Barnes, 1984) 
Bacteroides endodontalis 
(van Steenbergen et al., 1984) 
Porphyromonas gingivalis 
(Shah and Collins, 1988) 
Porphyromonas asaccharolyticus 
(Shah and Collins, 1988) 
 
Porphyromonas endodontalis (266) 
Bacteroides gingivalis (Coykendall et al., 1980)  
Porphyromonas endodontalis 
(Shah and Collins, 1988) 
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pathogenicity factors of this bacteria support the adhesion and colonization following by the 
maturation of other virulence. 
 
1.4.1 Gingipains 
 Gingipains are the vital virulence factors secret by P. gingivalis. These proteases are responsible 
for several activities in the infection progress, including attachment and colonization, acquisition 
of nutrients, evasion of host defense, and tissue invasion and dissemination (Guo et al., 2010). 
Gingipains play a key role in the pathogenic functions of P. gingivalis, including fimbriae 
assembly and processing of extracellular proteins. Correspondingly gingipains completely digest 
several host proteins such as collagen, fibronectin, immunoglobulin G, and TNFα (Cutler et 
al.,1995) to provide peptides for P. gingivalis growth and metabolism. It also limits proteolysis, 
which leads to the dysregulation of host defensive inflammatory reactions and failure to eradicate 
P. gingivalis, as well as mediate nutrient acquisition through hemagglutination, hemolysis, and 
iron uptake from heme within sites of periodontal infection (Smalley et al., 2008). In addition, 
these proteins develop the attachment of P. gingivalis to host tissue cells and other bacteria, 
stimulate extracellular matrix protein degradation, increase vascular permeability, induce cleavage 
of host cellular receptors, and processing the fimbrillin subunit (Inomata et al., 2009, Lourbakos 
et al., 200; Tichy and Novak, 1998). 
 Gingipain family comprises three related cysteine proteases identify as arginine-specific 
gingipains (RgpA and RgpB) and Lys-specific gingipain (Kgp). The first two proteins are products 
of two related genes rgpA and rgpB, whereas the Lys-gingipain (Kgp) is encoded by the kgp gene 
(Fitzpatrick et al., 2009). The gingipains are accumulated on the surface of P. gingivalis from 
where subfractions are secreted into the extracellular fluid (Amano, 2003). On the bacterial 
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membrane surface, RgpA and Kgp form multifunctional complexes that engage in proteolysis, 
heme acquisition, platelet activation, red blood cell agglutination, hemolysis, and adhesion to the 
extracellular matrix. All gingipains, including RgpB, RgpA, and Kgp, have a large 
hemagglutinin/adhesion domain inserted between the protease and C-terminal domains. However, 
RgpB is distributed into the periplasm as a proprotein consisted of an N-terminal prodomain, a 
protease domain, and a C-terminal domain. During the translocation squarely outer membrane, the 
pro-gingipains subject to proteolytic process leads to cleavage of the N-terminal prodomain and a 
C-terminal domain. Nevertheless, the hemagglutinin domain in RgpA and Kgp is fragmented into 
subdomains bound to the protease domain via non-covalent interactions (Sztukowska et al., 2012). 
 
1.4.2 Hemagglutinins 
 The adherence of P. gingivalis to host tissues and other bacterial pathogens is a vital step in 
periodontal disease initiation (Okuda et al., 1986). Fimbriae mediates adherence to other oral 
bacterial species and numerous host components such as hemoglobin, collagen, fibronectin, and 
periodontal cell surfaces (Amano et al., 2003; Cutler et al., 1995). Moreover, Hemagglutination 
activity is one of the major phenotypic characteristics that distinguish P. gingivalis from other oral 
and nonoral asaccharolytic black-pigmenting species (Holdman et al., 1986). Hemagglutinins are 
a large class of virulence factors that P. gingivalis produces (Han et al., 1996; Lee et al., 1996; Shi 
et al., 1999) to agglutinate erythrocytes of sixteen animal species, including human erythrocytes 
regardless of their blood type (Hanazawa et al., 1988). Furthermore, hemagglutinins associated 
with lipopolysaccharides and cell surface lipids, in hemagglutination and hemolysis activities 
along with other enzymes to bind erythrocytes and epithelial cells. Then indorse the colonization, 
maturation, and acquisition of hemin and iron from hemoglobin found in host erythrocytes to allow 
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the proteolytic gingipains releasing the heme moiety from the hemoglobin molecule through dual 
uptake system known as HmuY/HmuR  (Lewis et al., 2006; Olczak et al., 2008; Okuda et al., 
1986). Porphyromonas gingivalis possess more than eight hemagglutinins encoded by a group of 
five genes known commonly as the hag genes (hagA, hagB, hagC, hagD, and hagE). Subsequently, 
these genes are subdivided into two distinct families. The first consists of hagB and hagC that 
share 93% identity, whereas hagA, hagD, and hagE comprise the second family with more than 
70% homology. HagA and hagB are major hemagglutinins of P. gingivalis (Bélanger et al., 2012; 
Song et al., 2005). HagA plays a vital role in co-aggregation of P. gingivalis with other microbial 
species such as T. denticola (Ito et al., 2010). Therefore, contributing to the ecology of the plaque 
biofilm. HagB accelerates the early infection process in experimental animal models (in vivo) (Lee 
et al., 1996). Additionally, they are necessary for the viability of P. gingivalis by assisting its 
adherence to oral epithelial cells (Lamont et al., 1995; Dorn et al., 2000) and biofilm formation 
(Connolly et al., 2015). 
 
1.4.3 Fimbriae  
 In the outer surface membrane of P. gingivalis, several specific protrusions are produces called 
fimbriae. Fimbriae are responsible for mediation of several processes in inflammation events such 
as adherence and invasion of host cells (Nakagawa et al., 2002; Yilmaz et al., 2002), colonization 
within the oral environment (Maeda et al., 2004), auto-aggregation (Lin et al., 2006), and induction 
of the host immune response (Hajishengallis et al., 2009). Fimbriae are categorized into two 
groups: major fimbriae which are composed of the fimbrillin protein (FimA, a 41-kDa protein 
encoded by the fimA gene) (Dickinson et al., 1988) and minor fimbriae which are composed of 
the 67-kDa mfa1 protein encoded by the mfa1 gene (Hamada et al., 1996; Park et al., 2005). The 
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fimbrillin protein plays an essential role in the attachment to a variety of oral structures and 
subsequent invasion of the host cells. It has been shown to mediate adherence to human gingival 
fibroblasts and epithelial cells (Njoroge et al., 1997; Sugano et al., 2004; Weinberg et al., 1997) as 
well as to induce periodontal bone loss in rat models (Malek et al., 1994). Instead, the minor 
fimbrial protein, mfa1, has been shown to elicit an inflammatory response in a mouse model 
(Hiramine et al., 2003). Besides, the enabling of co-aggregation with other bacteria, such as S. 
gordonii (Lamont et al., 2002). 
 
1.4.4 Lipopolysaccharides  
 Lipopolysaccharides (LPS) are components of the outer cell membrane of all gram-negative 
bacteria. They play a harmful role in chronic periodontitis (Park et al., 2010; Trent et al., 2006). It 
has been found that the LPS has influenced by multiple factors, such as its structure (Hajjar et al., 
2002) and growth conditions (Lee and Baek, 2013) including temperature (Curtis et al., 2011) and 
the hemin level (Al-Qutub et al., 2006; Cutler et al., 1996). A high level of hemin in the 
environment results in a change of some lipids structure, resulting in immune suppression (Reife 
et al., 2006). Equally, low levels of hemin result in immune evasion. Accordingly, hemin 
concentration in the surrounding environments and the associated lipid structure might help protect 
other bacteria and support biofilm formation (Coats et al., 2009). 
 
1.5 P. gingivalis strains 
 P. gingivalis has many strains classified as invasive or non-invasive strains based on the ability 
to cause the inflammation, at which they vary in their pathogenicity and ability to attack tissues 
and cells (Dorn et al., 2000; Lundberg et al., 2010; Dolgilevich et al., 2011; Olsen and Progulske-
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Fox, 2015). Up to the present, about eight completed strains of nineteen P. gingivalis genome 
sequences have been published, including W83, ATCC 33277, TDC60, HG66, A7436, AJW4, 381, 
and A7A1-28. Besides eleven high-coverage draft sequences (JCVI SC001, F0185, F0566, F0568, 
F0569, F0570, SJD2, W4087, W50, Ando, and MP4-504).These strains were isolated from several 
sources using laboratory cultures through diversity in the degree of virulence, clinical samples 
from patients with different disease states, and an environmental strain isolated from a hospital 
bathroom sink drain (Tsute et al., 2017). The most aggressive strain has been isolated from a severe 
periodontal lesion at Tokyo Dental College in Japan named TDC60. This strain exhibited higher 
pathogenicity in causing abscesses in mice than strains W83 and ATCC 33277 and other strains 
(Watanabe et al., 2011). This strain is also found to be the most divergent sequence among all 
nineteen P. gingivalis genomes on the base of 16S rRNA gene sequences that are very similar and 
frequently have a single number of nucleotides mismatches between any two strains. Moreover, 
the TDC60 strain has several unique proteins compared with other strains based on the percentage 
of the unique proteins identified by Tsute et al. (2017). For its unique features and aggressiveness, 







Fig.1.4 Cell morphology and growth of Porphyromonas gingivalis. The bacterium forms rod and 
black colonies growth anaerobically in blood agar culture. Several proteases secreted in the outer 
cell membrane, which are the virulence factors of this bacterium. 
  
1.6 Treatment of periodontal diseases 
 The treatment of periodontal diseases depends on the stage and severity of the infection. There 
are differences between chronic and aggressive periodontitis. At the same time, the clinical 
appearance of both entities is similar, through periodontal loss of attachment, presence of local 
inflammation, loss of collagen, and then a loss of bone support. Thus, the periodontal treatment 
for both is similar and directed to achieving an adequate level of plaque control and reduction in 
pocket probing depth. Periodontal treatment can be performed in five steps, including mechanical 
therapy, antimicrobial therapy, host modulation therapy, tissue regeneration therapy, and 
behavioral and economic concerns (Chapple, 2009). The first phase of periodontal treatment 
involves mechanical debridement of supra and subgingival microbial plaque and calculus from 
teeth and surrounding structures. The removal of sub-gingival plaque from deep periodontal 
pockets is difficult. However, the re-colonization of these sites by pathogenic microbes is tackled 
by using antimicrobial agents and antiseptic substances. More novel approaches enhancing the 
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immune response might hold promise but are not in general use yet. This approach focus in the 
suppression of periodontal destruction (Chapple, 2009), vaccination against certain virulent 
microorganisms, and stimulation of T cells into the regulatory subtype (Choi and Seymour, 2010). 
Besides the use of certain pro-resolving lipid mediators of inflammation such as lipotoxin, 
resolvins, and protectines (Serhan, 2008; Van Dyke, 2008). Another approach adopted by some 
specialties is the replacement of lost soft and hard tissues (Chapple, 2009). Enamel matrix 
derivatives have been used in tissue regeneration therapy and act by promoting the process of 
periodontal regeneration (Bosshardt, 2008). Emdogain is one of the agents that has been shown, 
in vitro, to stimulate the proliferation of periodontal ligament cells (Gestrelius et al., 1997) and to 
increase the attachment of periodontal ligament fibroblasts to the diseased root surfaces 
(Davenport et al., 2003) with enhancement of matrix synthesis (Haase and Bartold, 2001). 
Therefore, it represents a possible alternative to open surgical debridement (Esposito et al., 2004, 
Venezia et al., 2004). 
 The Current strategies for developments of anti-pathogenicity agents work in the understanding 
of the mechanism of virulence factors processing and secretion, which recognized as beneficial 
targets for the therapeutic process. It is well known that P. gingivalis cell adhesion predominantly 
relies on the functions of hemagglutinins and gingipains. Therefore, using of antiadhesive 
compounds that influence the interaction between virulence factors and host proteins could hinder 
periodontitis in the early stages of the inflammation (Miyachi et al., 2007).  The rising in disease 
incidence (particularly in developing countries) with increasing resistance by pathogenic bacteria 
to currently used antibiotics and chemotherapeutics, opportunistic infections in immune-
compromised individuals, and financial considerations worldwide, specifically in developing 
countries. Consequently, the globe requires alternative prevention and treatment options and 
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products for oral diseases that are safe, low-priced, effective, and economically available (Badria 
and Zidan, 2004; Lachenmeier. 2008). The most recent strategy for the invention of a new 
therapeutic agent against P. gingivalis focuses on blocking the very early steps of the bacterial 
adhesion to the host cells through the inhibition of virulence factors. Over the past few years, plant-
derived natural products, mainly polyphenols and polysaccharides (Alshafei et al., 2016), have 
been described as a putative adjunctive therapy that aims to reduce inflammation as well as 
interface with the adhesion agents of P. gingivalis. The naturally occurring products derived from 
medicinal plants have proven to be a rich source of biologically active compounds. Most of them 
have been the basis for the development of new lead chemicals for pharmaceutical applications. 
Sudan is the third-largest country in Africa with a diverse climate that contributed to its diverse 
and vibrant flora. Most of the Sudanese people in rural areas rely on traditional medicine to treat 
many infectious diseases. In this study, we select 38 plant organs from 25 plant species 
traditionally used in the Sudanese folkloric medicine to investigate their effect on P. gingivalis 
growth and virulent factors (Table 1.1).  
 
1.7 Overview of selected medicinal plants and isolated biological compounds 
 Sudanese traditional medicine is characterized by a unique combination of Islamic, Arabic, and 
African cultures. Traditional medicines continue to be used for human illnesses treatment in many 
African countries and in various parts of the world. The useful components derived mainly from 
natural products such as herbs, plants, and animals. (Karar and Kuhnert, 2017). In Sudan, 90% of 
the population relies on traditional medicine (Elegami et al., 2002; Koko et al., 2000). Several 
plants have been used for oral disease treatment (El Ghazali et al., 2003; Khalid et al., 2012). Based 
on the ancient and traditional uses of plants and plant parts in Sudanese folk medicine, we have 
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selected 38 organ parts from 25 plant species (Table 1.1) to investigate the potential inhibitory 
activities of the plant aqueous extracts prepared following the traditional way. Most of the selected 
Sudanese plant aqueous extracts revealed an influence on either P. gingivalis proliferation and/or 
its virulence factors. However, among the plants chosen, Origanum vulgare leaves extract was 
non-specific on the inhibition activity. It showed a reliable suppression against P. gingivalis 
proliferation and virulence factors. In contrast, the aqueous extract of Monechma ciliatum had a 
potent inhibitory activity on P. gingivalis exo-hemaglutinins compared to the other tested plants.  
Solenostemma argel had a potent activity on the impedance of P. gingivalis growth and 
proliferation. The three plants extract were selected for isolation, purification, and identification 
of the inhibitory compounds.  
 
1.7.1 Origanum vulgare  
 Origanum vulgare is known as oregano (Fig.1.5), which use as a spice all over the world 
(Lawrence, 1984). It is an annual herb widely distributed in Eurasia, North Africa, and North 
America (Ayoub et al., 1984). This plant belongs to the family of Lamiaceae. The family is divided 
into several subspecies as hirtum, vulgare, viridulum, glandulosum, gracile vulgare, virens and 
subspecies viride (Letswaart, 1980). It has light green to greenish-brown leaves, about 3 cm long 
with crenate to crenate-serrate margins and glandular punctate. It has spike-like clusters flowers 
which are bracts – broadly ovate, 2.5-3 × 2 mm with prominent hairs on the outer surface (Bagchi 
and Srivastava, 2003). Oregano has a robust camphoraceous odor and a warm, pungent, bitter, 
camphoraceous taste. The plant is collected when in flower and dried in the shade at less than 
35 °C (Bagchi and Srivastava, 2003).  It has been used traditionally to treat several illnesses 
because of its carminative, diaphoretic, expectorant, stimulant, stomachic, and tonic effects. 
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Furthermore, it is used against colic, coughs, headaches, nervousness, toothaches, and irregular 
menstrual cycles (Kintzios, 2002). O. vulgare oil has been used as an antimicrobial against bacteria, 
fungi and yeast species (Sahin et al., 2004). O. vulgare oil's chemical composition mainly contains 
the mono and sesquiterpenes (Skoula and Harborne, 2002; Stahl-Biskup, 2002), carvacrol, thymol, 
p-cymene, α and β-pinene, myrcene, limonene, linalool, and estragol (Sivropoulou et al., 1996; 
Milos et al., 2000, Aligiannis et al., 2001; Azizi et al., 2009). The phenolic components in the 
essential oil of oregano, such as carvacrol and thymol, have a strong antifungal power (Curtis et 
al., 1996). Adam et al. (1998) reported that carvacrol and thymol showed higher antifungal 
activities against human pathogens than p-cymene and γ-terpinene. Additionally, the aqueous and 
methanolic extract of O. vulgare has antioxidant activity and is applied in human health. Cervato 
et al. (2000) prove that the antioxidant activities of oregano leaf extract (both aqueous and 
methanolic extracts) can inhibit all phases of lipid peroxidative process. In this study, a wide range 
of inhibitor has been isolated from the aqueous extract of O. vulgare leaves against P. gingivalis 




Table 1.1: List of selected Sudanese plants and their traditional medical uses 
Scientific name Family Local name Traditional uses 
Tamarindus indica L. Fabaceae Aradeb The fruits are used to treat constipation, malaria, jaundice, and 
toothache. 
Salvadora persica L. Salvadoraceae Arak  Mouth wash and to facilitate digestion. The fruits are used to treat 
hypertension, stomach pain, and wounds, and the leaf-fibers are used 
to treat eye infections. 
Erythrina abyssinica L. Fabaceae Habalaroos The bark is used to treat snake bites, malaria, sexually transmittable 
diseases such as syphilis and gonorrhea, amebiasis, cough, liver 
inflammation, stomachache, colic, and measles. 
Origanum vulgare L. Lamiaceae Bardagosh It is used as an antibacterial agent to reduce spoilage of fatty acids in 
food products such as meat and digestion aid. 
Ambrosia maritima L. Asteraceae Dimsisa The herbs are used as an anti-malaria treatment, to treat urinary tract 
infections, and to eliminate kidney stones. The leaves are used as an 
anti-diabetic and anti-hypertensive agent. 
Acacia nilotica (L.) Willd. 
ex Del 
Fabaceae Garad The fruits are burned, and the fumes are inhaled to treat colds and 





Combretaceae Gubesh The leaves are used as an anti-hypertensive and anti-diabetic agent. 
Grewia tenax (Forssk.) 
Fiori 
Malvaceae Gudeim The fruits are used to treat malaria and iron deficiency anemia. 
Solenostemma argel (Del.) 
Hayne 
Ascepiadaceae Harjal  The leaves are used as an antispasmodic, carminative, anti-diabetic 
agent and to treat malaria.  
Trigonella foenum-
graecum L. 
Fabaceae Hilba The seeds are used as an antidiarrheal, antispasmodic, anti-amoeba, 
dysentery, and anti-diabetic agent. The seeds are also used as a food 
additive to increase milk secretion in lactating mothers and facilitate 
expulsion of the placenta. 
Balanitesa egyptiaca (L.) 
Del. 
Balanitaceae Hijlij Purgative, wound healing, anti-rheumatic, anti-diabetic, anti-
anthelmintic. Fruits are used to treat dysentery and constipation. 
Seed oil is used to treat tumors and wounds. 
Glycyrrhiza glabra L. Fabaceae Irgsoos It use as anti-allergy, to treat HIV-1, Japanese encephalitis, yellow 
fever. Acts as an anti-carcinogenesis, anti-diabetic and anti-
inflammatory agent. In the past, it was used for its anti-viral activities 





Ceratonia siliqua L. Fabaceae Kharoub To relieve pain and to prevent and treat osteoclasis and osteoporosis. 
Acacia oerfota (Forssk.) 
Schweinf. A. nubica 
Benth 
Fabaceae Laoot It used as anti-rheumatic,  to treat snake bites, swelling, and scorpion 
bites. 
Khaya senegalensis 
(Desv) A. Juss 
Meliaceae Mahogani The stem bark is used to treat malaria, hepatic inflammation, and 
enteriogasteritis. The leaves are used to treat skin diseases and 
trachoma. 
Cymbopogon 
schoenanthus (L.) Spreng. 
Ssp. Proximus 
Poaceae Mahareb The leaves are used to treat gout, renal colic, helminthiasis, and 
inflammation of the prostate. 
Monechma ciliatum Acanthaceae Mahlab 
aswad 
Effective laxative. It believed to ease general body pain, liver, bowel 
troubles (diarrhea), and sterility in women. 
Salvia officinalis (Sage) Lamiaceae Merameya Traditionally used to treat many disorders such as seizure, ulcers, 
gout, rheumatism, inflammation, dizziness, tremor, paralysis, 
diarrhea, and hyperglycemia 








    
Lepidium virginicum L. Brassicaceae Rashad Used to treat madura foot, as an anti-asthmatic, and for treating 
diarrhea. 
Cyperus rotundus L. Cyperaceae Sedaa Diuretic, carminative, emmenagogue, anthelminthic, stomachic, 
stimulant, analgesic, hypotensive, anti-inflammatory, anti-
dysenteric, and anti-rheumatic agent.  
Leptadenia arborea 
(Forssk.) Schweinf 
Asclepiadaceae Shaaloub Taken as a stem decoction to facilitate expulsion of the placenta after 
birth and is applied to stop bleeding after circumcision. It is also 
considered as a tonic and to treat diabetes. In Comoros, a stem 
decoction containing several other plant species is taken to treat fever 
and colic. 
Ziziphus spina-christi (L.) 
Desf. 
Rhamnaceae Sidr Antispasmodic used to treat gonorrhea and as anti-purgative. 
Acacia seyal var. seyal 
Del. 








1.7.2 Tannins  
 Tannins are extensively distributed in plants and food of plant origin, including fruits, legume 
seeds, and cereal grains besides different beverages (tea, cocoa, and cider). Tannins are divided 
into two groups. Hydrolysable tannins are esters of phenolic acids such as either gallic acid in 
gallotannins or other phenolic acids derived from the oxidation of galloyl residues in ellagitannins 
and a polyol with glucose (Clifford and Scalbert, 2000). The other tannins are proanthocyanidins, 
which are common in our food and produce anthocyanidins upon heating in acidic media. They 
are polymers made of elementary flavan-3-ol units. Structurally, tannins possess a huge number 
of phenolic groups with several aromatic rings per 1000 units of relative molecular mass (Haslam, 
1998). That explains their high molecular weight, which makes the tannins and similar phenolic 
polymers found in processed food products such as red-black tea different in structure and 
properties from the low-molecular-weight phenolic acids and monomeric flavonoids. The phenolic 
polymers, formed by enzymatic and/or chemical transformation of simple flavanols, 
proanthocyanidins, and other phenolic compounds known as tannin-like compounds (Lewis et al., 
1990). Tannins are Water-soluble phenolic compounds with molecular weights between 500 and 
3000 m/z. These compounds have unique features, reactions, and unique properties, such as the 
ability to precipitate several proteins like gelatin and alkaloids (Haslam, 1989). Tannins precipitate 
salivary proteins in the oral cavity, which gives the feeling of an astringent known in tannin-rich 
food. This property is essential to explain their role in plant protection against pathogens (Scalbert, 
1991) or to deter herbivores from feeding on tannin-rich plants (Feeny, 1970). Tannins have 
valuable benefits for health. Numerous studies have reported the anticarcinogenic, antioxidative, 
antimicrobial activities of tannins. As well as tannins inhibited the growth of many fungi, yeasts, 




1.7.3 Monechma ciliatum  
 Monechma ciliatum known as Black mahlab, it belongs to the Family Acanthaceae. This plant 
is an annual hispid scabrous or almost glabrous herb, 30-65 cm high, and woody below. It has a 
linear or narrowly linear-lanceolate leaves up to 10 cm long, and 1.25 cm broad (Massey, 1929). 
M. ciliatum flowers are cream-white with purple and orange strakes. Seeds are dark brown to black, 
with kidney shape (Fig.1.5), pods with a tuft of rigid thick hairs at the hilum, and similar tuft at 
the other end (Andrews, 1952). M. ciliatum is a native African plant in tropical areas and 
sometimes India. Distributed from Senegal to Cameroon and eastward to the central and southern 
provinces of the Sudan and south through East Africa, Zambia (Wickens, 1976) and Nigeria 
(Uguru, 1998). In Sudan, M. ciliatum grows widely in Kassala State (Galabat), Southern Blue Nile 
State (Jongol post), and Kordofan State (Elobeid). This plant has a crucial role in cosmetic and 
nutritional products in western Sudan. The oil is used to manufacture traditional fragrance and 
lotion. The plant has medicinal importance as a laxative medicine to remedy stomach troubles and 
used to control scale dandruff, which forms on the skin in case of oily hair. In Botswana, it believed 
that its useful for body pain, liver and bowel trouble (diarrhea), and sterility in women (Hedberg 
and Stengard, 1989). The seeds of this plant are rich with hydrocarbons and fatty acids such as 
palmitic, stearic, linoleic in addition to tocopherols and protein besides elements (K, Ca, Mg, Al, 
Pb, Ni, Mn, Cu, Cr, Co, and Fe) (Mariod et al., 2009) Furthermore, flavonoids, tannins, triterpens, 
and anthraquinones (Oshi, et al., 2010). In our study, we isolated and identified coumarin, oleic 





1.7.4 Fatty acids and its esters 
 The carboxylic acids resulted from the hydrolysis of triglycerides are known as fatty acids. 
Nutritional triglycerides represent the primary form of stored lipids at the small intestine of 
mammalian organisms. In addition to their biochemical role as a storage form of energy, fatty acids 
act as the bedrock of glycolipids and phospholipids, molecules that play essential structural and 
physiologic functions in the organism. Various fatty acids have been isolated from animals, plants, 
and microbial origins. Fatty acids might be formed in a single chain or branched chain. However, 
a few branched fatty acids have been isolated from plant and animal sources. The hydrocarbon 
chain may be a long or short chain of carbons with different saturation degree, unsaturated chain 
comprising of one or more double bonds, or saturated with no double bonds, by a terminal carboxyl 
group (Huang et al., 2010). The long-chain fatty acids are found to have antibacterial and anti-
inflammatory activities by serving as precursors to produce eicosapentaenoic acid and 
docosahexaenoic acid, which can reduce inflammation (Raffaelli et al., 2008; Kesavalu et al., 
2007). A study conducted by Huang et al. (2010) revealed three major polyunsaturated fatty acids 
(eicosapentaenoic acid, docosahexaenoic acid, α-linolenic acid) and their ester derivatives 
exhibited strong antimicrobial activity against various oral pathogens (Huang et al., 2010). A 
relationship has been found between the carbon chain length of n-6, n-7, and n-9 fatty acids and 
antimicrobial activities against oral microorganisms (Huang and Ebersole, 2010). 
 
1.7.5  Coumarin 
 Coumarins are secondary metabolites from plants, bacteria, and fungi (Iranshahi et al., 2009). 
They were initially found in tonka bean (Dipteryx odorata Wild) and are reported in about 150 
different species from 30 different families, of them, Rutaceae, Umbelliferae, Clusiaceae, 
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Guttiferae, Caprifoliaceae, Oleaceae, Nyctaginaceae, and Apiaceae. Chemically, coumarins 
(known as 2H-1-benzopyran-2-one) consist of a large class of phenolic substances found in plants 
and are made of fused benzene and 𝛼-pyrone rings (Aoyama et al., 1992). This compound displays 
anti-inflammatory properties and is used in the treatment of edema (Piller, 1975). It also exhibited 
anti-inflammatory activity in rat colitis induced by trinitrobenzene sulfonic acid (Witaicenis et al., 
2010; Kwon et al., 2011). Additionally, coumarins have anticoagulant activity (Aoyama et al., 
1992) as well as low antibacterial activity, but compounds having long chain hydrocarbon 
substitutions such as ammoresinol and ostruthin show activity against a wide spectrum of gram-
positive bacteria such as Bacillus megaterium, Micrococcus luteus, Micrococcus lysodeikticus, 
and Staphylococcus aureus (Hod´ak et al., 1976). Another coumarin compound anthogenol from 
green fruits of Aegle marmelos (Wiebe et al., 2000) shows activity against Enterococcus. 
Imperatorin, a furanocoumarin isolated from Angelica dahurica and Angelica archangelica 
(Umbelliferae) (Baek et al., 2000), shows activity against Shigella dysenteriae (Raja et al., 2011). 
In addition, inophyllums and calanolides represent novel HIV inhibitory coumarin derivatives 
(Luo et al., 2011).  Coumarins are had many pharmacological properties that lead to further study 
in their features. 
 
1.7.6 Solenostemma argel 
 Solennostemma argel (Fig.1.5), which locally known as harjel, is a desert plant indigenous to 
Africa and belongs to the family Apocynaceae and subfamily Asclepiadaceae (Elkamali and 
Khalid, 1996). It is a herbaceous perennial plant that grows up to 60-100 cm tall, with several 
vigorous stems. It has oval, leathery leaves covered with fine hairs. The flowers are many with 
white petals and a strong aroma. The fruits about 5 cm pods long and 1.5-2 cm wide, green with 
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violet lines, contain pubescent seeds (Elkamali, 2001). This plant found in many countries and its 
leaves extract one of the popular drinks and traditionally used as medicine in African countries 
(Sudan, Libya, Chad, Egypt, and Algeria), Saudi Arabia, and Palestine (Elkamali and Khalid 1996; 
Ahmed, 2004; Shayoub et al., 2013). In Sudan, S. argel initially found in the northern region 
(Orange, 1982) and widely spread in the places between Dongola and Barber, particularly around 
Abu Hamad area (Elkamali and Khalid, 1996). The folkloric uses of S. argel leaves as an anti-
inflammatory, anti-spasmodic, anti-rheumatic agent, carminative, and as an anti-diabetic (Shayoub 
et al., 2013; Kamel et al., 1982; Hassan et al., 2001; Idris, 2011). Moreover, Hanafi et al. (2010) 
and Plaza et al. (2005) reported anticancer activity from seeds extract of S. argel. The present study 
resulted in the isolation of pregnane glycoside with a very potent inhibitory activity on P. gingivalis 











1.7.7 Pregnane glycosides 
 Pregnane glycosides are a class of secondary metabolites compounds widely distributed in the 
plant kingdom. In traditional remedies, medicinal plants are generally used due to their secondary 
metabolites, which frequently found in glycosylated forms, such as steroidal, terpenoidal, cardiac, 
and pregnane glycosides (Williams et al., 1989). Pregnane glycosides are polar compounds that 
form esters of a linear oligosaccharide chain with steroidal compounds through acetal linkage 
(Panda et al., 2006). Recently, pregnane glycosides isolated from many plant organs and 
recognized to have a pharmaceutical property with a good impact on health such as a pregnane 
glycosides isolated from Cynanchum atratum roots with inhibitory activity against 
acetylcholinesterase, which associated with Alzheimer disease (Lee et al., 2003). Oshima et al. 
(1987), isolated pregnane glycosides from Periploca sepium roots, exhibited significant anti-
complimentary activity. A study conducted by Liu et al. (2003) revealed that glycosides might 
either stimulate bone formation or have potential activity against osteoporosis. Moreover, 
anticancer activity was detected by three pregnane glycosides isolated from Dioscorea collettii 
rhizomes which inactive six cultured human tumor cell lines in the colon, prostate, and breast (Hu 
et al., 1999). 
 
1.8 Aims of the study  
 The thesis work was performed to screen the potency of a group of Sudanese medicinal plants 
traditionally used in the Sudanese folkloric medicine against P. gingivalis proliferation and 
virulence factors.   
The research was conducted with the following specific aims: 
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- Investigation of the inhibitory activity of 38 plant organs against P. gingivalis growth and 
its virulence factors.  
- Isolation, purification, and structure elucidation of the biologically active constituents 
impeded P. gingivalis proliferation and its pathogenicity factors, including hemagglutinins 
and gingipains in the outer cell membrane. 
- Understanding the structure-function relationship of the long-chain fatty acids on the 





Non-specific inhibitor from Origanum vulgare leaves restrains Porphyromonas gingivalis 
growth and virulence factors 
 
2.1 Introduction 
 Oral diseases are important and common chronic ailments (Kadowaki et al., 2004; Peres et al., 
2019). Of them, periodontal disease (periodontitis) is caused by bacterial inflammation of the 
tissues supporting the teeth and is a major oral health problem. Periodontal disease causes different 
symptoms and can result in the loss of teeth. Additionally, recent studies have demonstrated a 
strong association between periodontal disease and serious systemic diseases such as diabetes, 
atherosclerosis, stroke and coronary heart diseases (DeStefano et al., 1993; Beck et al., 1999; Beck 
et al., 2017). 
 Many different bacteria exist simultaneously in the oral cavities of patients with periodontal 
disease. In particular, Porphyromonas gingivalis is a gram-negative, asaccharolytic, obligate 
anaerobic rod bacterium and appears to be the prime etiological agent in the pathogenesis and 
progression of the inflammatory events underlying periodontal disease (Gron et al., 1997; Kan et 
al., 2019). P. gingivalis requires exogenous amino acids, porphyrin, and iron for growth and 
virulence through production of several virulence factors such as hemagglutinins and gingipains. 
Hemagglutinins attach to the host tissues and lyse erythrocytes to uptake Fe ions as an essential 
nutrient; peptidases degrade connective-tissue proteins into small peptides and amino acids for use 
in growth and metabolism. In addition, gingipains are cysteine proteinases in P. gingivalis that are 
believed to be major virulence factors (Snipas et al., 2001; Lamont et al., 2018). Compounds that 
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suppress the adhesion of P. gingivalis to teeth by suppression of these virulence factors represent 
a new strategy for preventing periodontitis (Cutler et al., 1995; Kan et al., 2019).  
 Pathogenic bacteria are increasingly resistant to currently used antibiotics and 
chemotherapeutic medications and thus medicinal plants are being investigated for alternative 
treatment options for oral diseases. The use of medicinal plants is generally safe, and they are 
abundant, inexpensive, and cost-effective, particularly in developing countries. Medicinal plants 
are a treasure trove of biologically active compounds, many of which have acted as lead 
compounds for the development of pharmaceuticals (Cheesman et al., 2017). 
 In Sudan, people have been using plant remedies to treat illnesses since ancient times. Many 
studies have verified the utility of Sudanese medicinal plants for treating various diseases, 
including bacterial and fungal infections. However, little has been reported to date regarding the 
inhibitory activities of Sudanese plants on the growth of P. gingivalis (Mohieldin et al., 2017). To 
the best of our knowledge, the inhibition activities of Sudanese medicinal plants against 
hemagglutination, hemolysis, and gingipain has not been investigated. Furthermore, several 
researchers have hypothesized that inhibition of gingipains is independent of cell growth 
suppression (Niehues et al., 2010; Messing et al., 2014; Feghali et al., 2012; Kushiyama et al., 
2009). Therefore, in this study, we focused on blocking the primary phases of bacterial adhesion 
to the host by preventing hemolysis, specifically through the inhibition of hemagglutinins and 
proteases that provide nutrients to P. gingivalis for their growth and survival.The inhibitory 
activities of the aqueous extracts of 38 plants were evaluated against hemagglutinins, hemolysis, 
gingipain and bacterial growth. Among them, Origanum vulgare suppressed all virulence factors. 
Following phytochemical analysis, the inhibitory activity of isolated and related bioactive 
compounds was investigated. 
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2.2 Materials and methods 
2.2.1 Preparation of plant aqueous extracts 
 Plant samples were collected from different areas in the state of Khartoum in Sudan. The 
voucher specimens were prepared and identified at the faculty of agriculture and the faculty of 
forest, university of Khartoum, Khartoum, Sudan. The list of selected plants and their folkloric 
uses are presented in Table 1.1. Cleaned and powdered plant materials were extracted three times 
with distilled water (ratio of 1 g sample to 10 mL water) for 30 min at room temperature. The 
supernatants were collected by centrifugation, and then filtered and lyophilized. The yields of 
crude extracts are listed in Table 2.1 The plant extracts were stored at −20°C and used for bioassays. 
 
2.2.2 Cultivation of P. gingivalis 
 P. gingivalis strain TDC60 (Watanabe et al., 2011) was provided by the RIKEN BRC 
Bioresource Center, Microbial Materials Development Office (JCM), through the National Bio-
Resource Project of MEXT, Japan. The strain was grown in tryptic soy blood agar medium Agar 
Base EH; DifcoTM, (Becton, Dickiton and Company, France), supplemented with hemin (5 mg.mL-
1), menadione (1 mg.mL-1) and horse blood at 37°C under anaerobic conditions for 4–5 days (Gao 
et al., 2010; Rangarajan et al., 2017). The bacterial cells were streaked on the agar medium and 
grew for 4 days at 37°C. Cells were collected and suspended in 1 mL of 20 mM Tris-HCl buffer 
(pH 8.0) per plate. Subsequently, the supernatant was ultrasonically disrupted for 3 min with Pulse 
ON 3 sec, Pulse off 20 sec, 70 Ampl using a micro ultrasonic homogenizer QSONICA Q 125 
(Wako Pure Chemical Industries, Ltd.). Sonicated cells were centrifuged at 10000 ×g for 15 min. 
The supernatant was designed as (Pg-A.sup) and the remaining precipitate was suspended with the 
same amount of Tris-HCl buffer as the supernatant as and named as (Pg-A.pre). 
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 For the samples prepared from the liquid medium, a small amount of P. gingivalis from agar 
medium inoculated into 5 mL Gifu Anaerobic Medium (GAM broth medium) (Umemoto et al., 
1996), and incubated anaerobically at 37°C for 2 to 3 days until the bacteria reached late stationary 
phase of bacteria growth as evaluated spectrophotometrically at 600 nm. The culture was 
centrifuged at 8000 ×g for 20 min at 4°C. harvested cells by centrifugation and the culture 
supernatant (Pg-sup).  In this study, the sample (Pg-sup) was used as the source of P. gingivalis 
virulence factors in the outer cell membrane. All the samples were stored at -20°C for further 
investigation. 
 
2.2.3 Hemagglutination and hemolytic inhibition assays 
 Erythrocyte aggregation (hemagglutination) and hemolytic assays were performed as described 
previously (Saiki and Konishi, 2007) with minor modifications. Horse defibrillated blood (Cosmo 
Bio Co., Ltd., Tokyo, Japan) was washed three times using  1× phosphate buffer saline (PBS), pH 
7.4 (8g of NaCl, 0.2g of KCl, 1.44g of Na2HPO4, and 0.24g of KH2PO4 in 1 L of  distilled water). 
The mixture was centrifuged (2000 ×g, 5 min, 4°C) and the supernatant was carefully removed.  
The washed erythrocytes were diluted to 5% (V/V) with PBS and stored at 4° C and then used 
within 6.0 h for the hemolysis and Hemaglutination assays. 
 For the hemagglutination test, 80 μL PBS, 10 μL Pg-sup, and 10 µL plant extract were mixed 
in a 96-well, round-bottom microtiter plate and shaken well. After incubation for 10 min at room 
temperature, 100 μL of the 5% washed horse erythrocyte suspension was added. Hemagglutination 
was evaluated visually after incubation at room temperature for 2 h.  
 The hemolysis of erythrocytes was observed visually. Briefly, 80 μL PBS, 10 μL Pg-sup, and 
10 µL plant extract were mixed in a 96-well flat-bottom microtiter plate and shaken well. After 
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incubation for 10 min at room temperature, 100 μL of the 5% washed horse erythrocyte suspension 
was added. The plate was incubated at 37°C for 2 h and centrifuged at 2000 ×g for 5 min, after 
which 100 μL supernatant was transferred to a clean plate and liberated hemoglobin was observed. 
In both hemagglutination and hemolysis assays, PBS was used instead of Pg-sup and plant extract 
as the negative control. The minimum inhibitory concentration was calculated from the final 
concentration of the lowest dilution exhibiting complete inhibitory activity.  
 
2.2.4 Protease inhibition 
 The protease inhibitory activity of plant extracts was determined as described previously (Kariu 
et al., 2017). Compounds exhibiting activity inhibitory to gingipains were identified using t-
butyloxycarbonyl-L-valyl-L-prolyl-L-arginine-4-methylcoumaryl-7-amide (Boc-VPR-MCA) as a 
protease substrate. Ten microliters of Pg-sup and 10 μL of plant extracts were added into the 
mixture containing 40 μL of 0.5 M Tris-HCl buffer (pH 7.5) and 30 μL of distilled water contain 
5 mM of L-cystein. After 5 min preincubation at 37°C, 10 μL of 500 μM Boc-VPR-MCA was 
added to the mixture. The release of amino methyl-coumarin was measured with an excitation at 
380 nm and emission at 440 nm using a fluorescence spectrophotometer (Infinite M 200 Pro, 
TECAN, Männedorf, Switzerland, Japan). The linear increase of amino methyl-coumarin release 
was recorded for 5 min in the presence or absence of aqueous crude extracts at different 
concentrations and the half maximal inhibitory concentration (IC50) was calculated from the 






2.2.5 P. gingivalis growth inhibition 
 The influence of the plants’ aqueous extracts on P. gingivalis growth was investigated by 
measuring the turbidity of bacterial suspension in a 96-well microplate. Ten microliters of plant 
extracts (20 mg.mL-1) was added to 200 μL of P. gingivalis suspension standardized at 2 x107 CFU 
(Kariu et al., 2017). The plates were incubated anaerobically at 37°C for 60 h. The turbidity was 
then measured at 600 nm via a microtiter plate reader (Model 680, Bio-Rad Laboratories Inc., 
Hercules, CA, USA).  
 
2.2.6 Isolation of biologically active compounds 
 The extraction of the inhibitory active constituents from O. vulagareleaves (Fig.2.1) was 
performed according to the method described by Mendonça-Filho (2006). About 40 g of dried and 
powdered leaves was extracted three times with 400 mL distilled water for 30 min at room 
temperature. The soluble extracted compounds were collected by filtration followed by 
centrifugation. The extract was portioned between distilled water and ethyl acetate. The water 
phase was fractionated using methanol precipitation (30% methanol for 20 min). The supernatant 
of methanol which had the highest activity for inhibition of hemagglutination, hemolysis and the 
protease, was fractionated using an ODS column (Cosmosil 75C18-OPN; Nacalai Tesque, Kyoto, 
Japan) eluted first with MeOH in H2O (0–80%, 20% increments) and then absolute methanol. The 
40% methanol fraction exhibited the highest activity and was subjected to silica gel column 
chromatography (Daisogel IR-60-63/210; Daiso, Osaka, Japan) by eluting first with 
acetone/hexane (0–100%), then 100% methanol, and finally distilled water. The compounds in the 
water eluate were fractionated using a C18 Sep Pak column cartridge (Sep-Pak C18 20 cc Vac 
cartridge, 5 g sorbent per cartridge, 55–105 µm particle size; Waters, USA). The column was 
35 
 
conditioned with MeOH and equilibrated with distilled water, then eluted with H2O/MeOH (0%, 
20%, 40%, 60%, 80%, and 100% methanol) to give six subfractions. The 60% methanol fraction 
exhibited the greatest inhibitory activity and was injected into a high-performance liquid 
chromatograph (HPLC) equipped with an ODS column (Cosmosil 5C18-AR-II, 4.6 ID  150 mm; 
Nacalai Tesque) and eluted using the following analytical conditions: gradient elution program, 
5–80% B/(A + B) within 60 min; solvents, milli-Q water (A) and acetonitrile (B); flow rate, 0.8 
mL.min-1; column temperature, 40°C; detection, UV 280 nm.  
 
2.2.7 Characterization of polymer-like compounds 
 The Prussian blue test was used to detect phenolic compounds as previously described (Price 
and Butler, 1977). Thin layer chromatography (TLC) on silica gel 60 F254 aluminum sheets 
(Merck, Darmstadt, Germany) was conducted to identify the types of large polyphenolic 
compounds isolated using 2-methyl-2propanol tert-butanol–acetic acid–water (3:1:1, v/v) as the 
mobile phase (Harborne, 1989). The compounds were detected using UV at 254 nm. Matrix-
assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS) was 
used to analyze the tannin (I. Tannin) isolated from O. vulagare and standard tannic acid obtained 
from Sigma-Aldrich (St. Louis, MO) using 2,5-dihydroxybenzoic acid as the MALDI matrix. I. 
Tannin (10 μL) (1.0 mg.mL-1) and tannic acid (1.0 mg.mL-1) were separately mixed with the matrix 
solution, and 1.0 μL was dropped onto the target plate and dried. The samples were analyzed using 





Fig.2.1 Scheme for isolating inhibitory compounds from O. vulagare  
 
2.3 Structural study 
 Cysteamine degradation was assessed as previously reported (Zhang and Lin, 2008). I. Tannin 
(50 μL, 4.0 mg.mL-1) was dissolved in 50 µL of 3.3% hydrochloric acid in methanol, added to 100 
μL of cysteamine hydrochloride in methanol (50 mg.mL-1), and heated at 40°C for 30 min. After 
cooling to room temperature, the solution was filtered (Φ13, 0.22 μm, Merck) and 10 μL of the 
sample solution was analyzed by HPLC. The remaining I. Tannin sample was partially acid 
hydrolyzed using a method described previously (Tanaka et al., 1986) by heating at 100°C in 5% 
sulfuric acid for 10 h. The solution was filtered and a 10μL aliquot was analyzed by HPLC using 
the following analysis conditions: elution solvents, 0.1% formic acid (A) and acetonitrile contain 
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0.1% formic acid (B); gradient elution (3–60%) over 10 min; column, Cosmosil C18, (ø 1.7 μm × 
50 mm); temperature, 40°C.  
 
2.3 Results 
2.3.1 Inhibitory activities of plant extracts against virulence factors in P. gingivalis 
 In this study we investigated 38 organ parts from 25 plant species belonging to 17 families. Our 
selection was based on the historical and traditional uses of plants and plant parts in Sudanese folk 
medicine. The potential inhibitory activities of aqueous extracts of these samples against P. 
gingivalis activities associated with periodontal disease were evaluated in a 96 well plate. The 
minimum inhibitory concentration (MIC) of each sample as determined by hemagglutination and 
hemolysis assays, and the IC50 value for protease inhibition, are summarized in Table 2.1. Except 
for the aqueous extract of Grewia tenax and Ziziphus spina-christi fruits, all tested samples 
exhibited inhibitory activities toward at least one tested parameter. Among the plant extracts, 23 
showed inhibitory activities against hemagglutination with MIC values of 0.06–4.0 mg.mL-1, 32 
inhibited hemolysis with MIC values of 0.03–4.0 mg.mL-1 and 16 plant extracts inhibited protease 
activity with IC50 values of 0.11–1.70 mg.mL
-1. 
 All plant extracts were tested at 1.0 mg.mL-1 for antibacterial activity against P. gingivalis. Ten 
of the 38 extracts exhibited inhibitory activity, with four extracts suppressing growth 81–100%, 
two suppressing growth 61–80%, and four extracts suppressing growth 50–60%. Although, several 
plant extracts showed potent inhibitory activities against virulence factors or cell growth 
independently, only, the leaf extracts of O. vulgare and aerial part extracts of Glycyrrhiza glabra 
and Salvia offinalis suppressed all the tested virulence factors and bacterial growth.  
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Table 2.1: The inhibitory activities of the aqueous extracts from selected Sudanese medicinal 
plants against Porphyromonas gingivalis virulence factors. 
A aerial part, B bark, D pod, L leaf, M stem, P peel, S seed, F fruit, Z rhizome. 
Yield %: based on dry weight 
ND: not detectable inhibition activity  
++ 81–100%, + 61–80%, 50–60%, - < 50% inhibition rate.  
 












Hemolysis   
Tamarindus indica F 72.9 ND 4   ND  - 
L 22.2 ND 1  0.14   - 
S 19.7 ND 0.03  1.03   - 
Salvadora persica  B 22.4 0.5 0.5  0.28   - 
L 38.3 4 0.5  ND  - 
M 12.6 4 0.5  ND  - 
Erythrina abyssinica  S 9.06 ND ND  0.13   - 
Origanum vulgare  L 21.1 0.25 0.25  0.34   + 
Ambrosia maritima A 15.1 ND 4  0.25   + 
Acacia nilotica D 15.5 ND 0.03  0.28   - 
Guiera senegalensis L 10.3 0.5 0.5  ND  - 
Grewia tenax  F 62.9 ND ND  ND  - 
S 30.1 0.5 4  ND  - 
Solenostema argel L 45.5 4 1  ND  ++ 
Trigonella foenum S 27.1 1 4  0.35   - 
Balanites aegyptiaca F 79.6 1 0.5  ND  +- 
L 34.0 ND ND  ND  +- 
P 34.8 1 1  ND  +- 
Glycyrrhiza glabra A 16.1 1 4  1.70   ++ 
Ceratonia siliqua  F 52.7 ND 4  ND  - 
S 21.2 4 4  ND  - 
Acacia oerfota M 11.1 4 4  ND  - 
Khaya senegalensis L 20.7 ND 1  ND  - 
Cymbopogon 
schoenanthus 
L 8.1 ND 1  ND  - 
A 14.8 4 1  ND  ++ 
Monechma ciliatum S 10.8 0.06 4  0.11   - 
Salvia offinalis A 19.5 4 0.25  0.18   ++ 
 L 19.7 4 4  ND  - 
Azadirachta indica L 29.4 ND 4  ND  - 
Lepidium sativum S 19.2 0.5 4  ND  - 
Cyperus rotundus A 81.3 4 0.5  0.53   - 
Z 6.1 4 1  ND  - 
Leptadenia arborea L 36.5 1 1  0.72   - 
Ziziphus spina F 59.5 ND ND  ND  - 
L 19.4 0.06 ND  0.14   - 
Acacia seyal  M 21.6 ND 0.03  0.96   - 
B 30.1 ND 0.5  0.35   - 
Capparis deciduas M 13.9 4 ND  ND  +- 
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Among these three plants, the aqueous extract of O. vulgare leaves exhibited the most potent 
inhibitory activity against all tested virulence parameters, and thus this sample was selected for 
further investigation and purification.  
 
2.3.2 Identification of inhibitory compound in the aqueous extract of O. vulgare leaves 
 The compounds in the O. vulgare leaf extract exhibiting inhibitory activity on virulence factors 
was extracted and identified as described above. HPLC analysis of purified aqueous extract of O. 
vulgare leaves provided a single, broad polymer-like peak (Fig.2.2A). Because of its heat 
resistance, high water solubility, and broadness of the single peak, we speculated that the active 
fraction harbors a polyphenolic or tannin-like polymeric compound. Colorimetric reactions of this 
active fraction and tannic acid with Prussian blue provided a dark blue to turquoise color, 
indicating that the isolated fraction contains a large polyphenolic or tannin-like compound 
(Fig.2.2B). We verified this possibility by TLC analysis (Fig.2.3) of the isolated fraction and 
standard tannin and found that the isolated fraction did not contain procyanidin oligomers and that 
the phenolic polymer provides a TLC profile similar to that of the tannic acid standard. 
 The isolated compound and tannin standard were analyzed using MALDI-TOF MS. The 
molecular mass of the isolated compound ranged from 509 to over 1000, and that of tannic acid 
from 530 to over 1500. The mass spectrum of the isolated fraction was similar but not the same as 
that of tannic acid: both showed peaks at similar intervals of 179 mass units for the isolated 
compound and 152 mass units (corresponding to gallic acid) for tannic acid (Fig.2.2C). The 
isolated tannin-like polymer was found to be stable against chemical degradation by cystamine 
(data not shown), confirming that the isolated compound is hydrolysable tannin. 
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 Identification of the monomer of the isolated tannin-like compound (I. Tannin) was carried out 
by subjecting it to acid degradation, followed by HPLC and absorbance spectrum analysis. 
Comparison of the HPLC chromatograms of the degraded isolated tannin-like compound with 
those of ellagic and gallic acids showed that the single peak of I. Tannin at 5 min corresponded to 
that of ellagic acid (Fig.2.4A). The UV spectrum of I. Tannin was somewhat similar to that of 






Fig.2.2 Characterization of polyphenolic compound isolated from O. vulagare. (A) HPLC 
chromatogram of the tannin-like compound and tannic acid. (B)The reaction of the isolated 
polyphenolic compound and tannic acid with Prussian blue. (C) MALDI-TOF MS analysis of 















Fig.2.4 HPLC chromatogram (A) of the acid-hydrolyzed tannin-like compound and UV spectrum 




2.3.3 Inhibitory activity of the isolated compound 
 The isolated tannin-like compound at 0.05 mg.mL-1 exhibited inhibitory activity against all 
tested periodontal factors, including P. gingivalis growth, hemagglutination (MIC: 0.0063 mg.mL-
1), hemolysis (MIC: 0.0063 mg.mL-1), and protease (IC50: 0.05 mg.mL
-1) (Table 2.2). Tannic acid 
also exhibited inhibitory activity against hemagglutination, hemolysis, and protease comparable 





Table 2.2: Inhibitory activity of the isolated tannin-like polymer against P. gingivalis virulence 
agents 
 
Compounds MIC (mg.mL-1)  IC50 (mg.mL-1) 
Gingpain Hemagglutination Hemolysis Growth   
Isolated tannin 
 
0.0063 0.0063 0.05  0.05  
Tannic acid 0.0063 0.0032 0.15  0.05 
 
 
2.4 Discussion and conclusion 
 The aqueous extracts from 38 plant organs from 25 plant species used in folkloric Sudanese 
medicine were evaluated for inhibition of virulence factors (hemagglutination, hemolysis, and 
protease activity) and for suppression of growth of P. gingivalis. Gingipains adhere to host cells 
to obtain the nutrients required for bacterial survival and the production of virulence factors. In the 
primary stages of inflammation, P. gingivalis secretes hemagglutinin and proteases which form 
large multifunctional complexes known as hemagglutinin/adhesion domains. These domains 
engage in proteolysis and are involved in the adhesion of host cells to red blood cells for acquisition 
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of heme through hemagglutination and hemolysis (Kadowaki et al., 2004; Tezuka et al., 2006; Guo 
et al., 2010; Kan et al., 2019). Several studies have, therefore, suggested targeting these virulent 
factors to block the primary stages of P. gingivalis pathogenicity, using natural, safe, and effective 
therapeutic agents (Nakayama et al., 1996; Kadowaki et al., 1998; Lu et al., 2019). Gingipains are 
obvious targets as their activity is independent of bacterial cellular programs and cell viability.  
 Most of the tested aqueous extracts inhibited one or more virulent proteins but only 10 plant 
extracts suppressed bacterial growth. This suggests that the inhibition of bacterial growth in a 
liquid medium and the outer cell membrane virulence of gingipains are achieved through different 
inhibition mechanisms. Similar findings were obtained using tea catechin, lactoferrin, cranberry 
proanthocyanidin, and prenyl flavonoids, all of which inactivated gingipains independent of 
bacterial growth suppression (Kushiyama et al., 2009; Niehues et al., 2010; Feghali et al., 2012; 
Messing et al., 2014). In contrast, leaf extracts of O. vulgare and aerial part extracts of G. glabra 
and S. offinalis suppressed gingipains and P.gingivalis growth, suggesting that they may harbor 
ideal inhibitors for all P. gingivalis virulence factors. No ideal periodontal inhibitor has been 
reported to date, thus further analysis to identify biologically active compounds in these plant 
extracts is essential. 
 Comparison of the MIC values of the three plant extracts (O. vulgare, G. glabra, and S. 
offinalis) showed that O. vulgare exhibited low MIC against all tested parameters especially for 
hemolysis and hemagglutination (Table 2.1). Hemagglutination is vital for P. gingivalis to adhere 
to host cells in gingival tissues and to uptake heme and iron by the aggregation and lysing of 
erythrocytes, resulting in the accumulation of dental plaque and the secretion of other virulent 
factors (Guo et al., 2010). Several natural and non-natural products have been reported to reduce 
P. gingivalis pathogenicity by blocking bacterial adhesion and decreasing proteolytic activity 
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(Löhr et al., 2011; Curtis et al., 2002; Yokoyama et al., 2007; Kan et al., 2019; Kariu et al., 2019). 
Since O. vulgare is used worldwide primarily as a food additive due to its pleasant aroma (Illias et 
al., 2018), we therefore, focused on aqueous extracts of O. vulgare leaves and succeeded in 
isolating a tannin-like compound as a non-specific inhibitor against all virulence agents. 
 Tannins are widespread in plants and in plant-based foods and are classified into two groups. 
The first group is hydrolysable tannins (HTs), which are esters of phenolic acids and a polyol, 
usually glucose. The phenolic acids are either gallic acid (in gallotannins) or phenolic acids derived 
from the oxidation of galloyl residues (in ellagitannins). The second group of tannins is 
proanthocyanidins (PAs), which are the most common type of tannin in our diet (Santos-
Buelgaand Scalbert, 2000; Smeriglio et al., 2017). Treatment with cystamine does not affect 
isolated tannins, perhaps due to the C-C or C-H linkages in tannins and their degree of 
polymerization. However, in this study, sulfuric acid degradation followed by HPLC analysis of 
the isolated and standard tannins, provided a single peak with a retention time and UV spectrum 
parallel to that of ellagic acid with a slight difference. This result indicates that the isolated tannin 
might be a derivative of ellagic acid and may be a new type of very polar HTs. 
 The isolated tannin-like compound exhibited high inhibitory activity against hemagglutination 
(MIC 0.0063 mg.mL-1), hemolysis (MIC 0.0063 mg.mL-1), protease activity (IC50 0.05 mg.mL
-1), 
and bacterial growth (MIC 0.05 mg.mL-1). These findings are in agreement with reports of 
antimicrobial properties of HTs in extracts from edible and non-edible plants (Santos-Buelga and 
Scalbert, 2000; Buzzini et al., 2008; Pinelli et al., 2015; Smeriglio et al., 2017). Several studies 
have reported an association between a reduction in polyphenolic compounds from green tea and 
cranberry polyphenols and an increase in dental diseases (Feghali et al., 2012; Kushiyama et al., 
2009). These polyphenolic compounds prevent biofilm formation by P. gingivalis and 
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Fusobacterium nucleatum and reduce the activity of several P. gingivalis proteases. Epicatechin-
3-O-gallate-(4β,8)-epicatechin-3′-O-gallate isolated from the aerial parts of Rumexa cetosa L. 
interacts with the active side of Arg-gingipain and hemagglutinin from P. gingivalis (Schmuch et 
al., 2015). Furthermore, the antimicrobial activity of flavogalonic acid dilactone and terchebulin 
from a methanolic extract of C. hartmannianum that inhibited metalloproteinase-9 matrix of P. 
gingivalis growth (Mohieldin et al., 2017).  
 The non-specific inhibition of HTs might be connected to their ability to neutralize free radicals 
(–R) by donating a hydrogen atom (–RH) or an electron (–R–), chelating metal ions in aqueous 
solutions, and binding or precipitation of proteins due to extensive coating of hydrophobic surfaces 
of peptides. To identify the real reasons and inhibition mechanism, more investigation is required 
of the chemical formula of HTs (Smith et al., 2005; Aaby et al., 2007). We conclude that the water 
extracts of the selected plants can play a potent role in blocking the very early stages of P. gingvalis 
virulence-related factors. Thus, targeting those virulent factors might hinder pathogenicity and 
improve the expansion of new, safe, effective therapeutic and/or preventative agents. It is a 
challenging and complicated task to impede all the virulence-related factors (Ingar and Potempa, 
2014). The HTs from O. vulgare leaves show a wide spectrum, impeding most of the targeted 
virulence-related factors in this study. The polarity and water solubility of this compound might 








Isolates from Monechma ciliatum seeds' extract hampered Porphyromonas gingivalis 
hemagglutinins 
3.1 Introduction 
 Periodontal diseases are major oral health problems caused by bacteria that induce 
inflammation in the tissues supporting the teeth. The primary stage of bacterial pathogenesis 
begins with the adhesion of bacterial cells to host tissues followed by colonization, which provides 
nutrients and allows bacteria to survive, grow, and produce further virulence factors (Beck et al., 
1999; DeStefano et al., 1993). Porphyromonas gingivalis, a gram‐negative anaerobic bacterium, 
is considered to be a major pathogen for periodontitis (Holt et al., 1999; Slot and Genco, 1984). 
This bacterium produces a number of molecules associated with adherence and colonization 
including fimbriae, lipopolysaccharides, proteases like gingipains, and potential adhesion 
molecules such as hemagglutinins, all of which are known as virulence factors (Connolly et al., 
2017). The most important virulence factor that P. gingivalis produces is the hemagglutinins (Han 
et al., 1996; Lee et al., 1996; Shi et al., 1999). This group of proteins plays a vital role in the 
infection process by allowing P. gingivalis to adhere to the surface of host cells. This, in turn, 
facilitates the acquisition of heme through erythrocyte binding and causes lysis and aggregation of 
erythrocytes via several proteolytic enzymes known as gingipains, which release the heme moiety 
from the hemoglobin molecule as a nutrient (Lewis et al., 2006; Olczak et al., 2008). It is well 
known that iron is an essential growth factor for most bacteria (Olczak et al., 2005). Unlike many 
other microorganisms, P. gingivalis does not possess a siderophore scavenging system for iron 
uptake or the enzymes required for heme biosynthesis. Instead, it employs alternative mechanisms 
to obtain iron from host heme (Gao et al., 2010; Smalley et al., 2011). For this process, P. gingivalis 
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possesses five different hemagglutinins located on the cell surface, in addition to secreting 
exohemagglutinins, which are responsible for effective binding to erythrocytes and epithelial cells 
(Okuda et al., 1986). The development of anti‐adhesive compounds against P. gingivalis 
hemagglutinins could be a promising cytoprotective strategy to prevent the harmful effects of long‐
term bacterial infection (Cutler et al., 1995). Over the past few years, plant‐derived natural 
products have been described as adjuvant remedies that aim to reduce inflammation through 
interaction with the adhesion of P. gingivalis to host cells (Kariu et al., 2017; Palaska et al., 2013). 
 Recently, we screened a number of medicinal plants used in Sudanese folk medicine to 
determine their inhibitory activity against virulence factors including hemagglutination of P. 
gingivalis (Eltigani et al., 2019). Among them, Monechma ciliatum exhibited potent inhibitory 
activity against hemagglutinins. M. ciliatum or black mahlab, belonging to the family Acanthaceae, 
is a famous medicinal plant that grows in some parts of arid and semi‐arid lands in tropical Africa 
including western Sudan, especially in the Nuba Mountains and Gabel Mara area (Oshi and 
Abdelkarim, 2013; Sharief, 2002). The seeds contain aromatic components and a high amount of 
oil. Thus, this plant is used mainly as a flavoring agent in traditional fermented bread, kisra, to 
give a sweet aroma to the final product. In addition, it is used in the production of traditional 
Sudanese fragrances, lotions, and other cosmetics used for wedding preparations and childbirth 
(Sharief, 2002). Black mahlab is also utilized as an effective laxative in several African countries. 
In Botswana, it is believed to diminish general body pain, liver problems, and bowel problems 
(diarrhea), as well as sterility in women (Hedberg and Stangard, 1989). In Nigeria, it is used to 
induce labor and facilitate menses. Furthermore, the dried leaves are powdered and burnt as an 
inhalation for colds (Uguru and Evans, 2000). In Sudan, the entire dried plant is used for diarrhea, 
vomiting, and as a perfume preparation (Sharief, 2002). However, despite its various traditional 
49 
 
uses, few studies have authenticated its use in folk medicine and determined the bioactive 
compounds responsible for its potential effects. Therefore, in the present study, we investigated 
the role of dried seed components against P. gingivalis hemagglutinins following aqueous 
extraction. The inhibitory activities of the four compounds isolated and purified for the first time 
from the aqueous extract of M. ciliatum seeds are discussed. 
 
3.2 Materials and methods 
3.2.1 Preparation of aqueous extract of M. ciliatum seeds  
 M. ciliatum seeds were obtained from Khartoum State, Khartoum, Sudan. The seeds were 
authenticated at the Faculty of Agriculture, University of Khartoum. Soluble compounds were 
extracted using distilled water (three times) from cleaned and powdered seeds (1 g sample: 10 ml 
water) for 30 min at room temperature under slow shaking. The supernatants were collected by 
filtration followed by centrifugation and lyophilization. The extract was stored at −20°C until 
analysis. 
 
3.2.2 Cultivation of P. gingivalis 
 P. gingivalis TDC60 (Watanabe et al., 2011) was cultivated and prepared as mentioned in 
chapter two. The bacterium was grown in Tryptic Soy Blood Agar medium anaerobically for 4–5 
days. Subsequently, the cells were then inoculated into 5 ml of GAM broth medium and incubated 
under anaerobic conditions at 37°C for 2–3 days then the growth rate was evaluated by a 
spectrophotometer at 600 nm and the cells were removed by centrifugation. The collected culture 




3.2.3 Inhibition of hemagglutination 
 Erythrocyte aggregation (hemagglutination) was performed as described in chapter two. Briefly, 
the hemagglutination test was performed in a 96‐well microtiter plate (round bottom) using a 
reaction mixture consisting of 80 μL of PBS, 10 μL of Pg‐sup, and 10 μL of plant extract. The 
mixture was shaken thoroughly and incubated for 10 min at room temperature. Then 100 μL of 
5% blood was added to the assay mixture. Hemagglutination was evaluated visually after 2 h of 
incubation at room temperature. PBS was used instead of Pg‐sup and aqueous extract of M. 
ciliatum as a negative control. The minimum inhibitory concentration was calculated from the final 
concentration of the lowest dilution with complete inhibitory activity. 
 
3.2.4 Isolation of biologically active compounds  
 Extraction of the active inhibitory constituents from M. ciliatum seeds (Fig.3.1) was performed 
according to the method described by Mendonça‐Filho (2006). About 100 g of dried and powdered 
seeds was used for the extraction of soluble compounds by soaking in 1.0 L of distilled water three 
times for 30 min at room temperature under slow shaking. The soluble extracted compounds were 
collected by filtration followed by centrifugation. The clarified extract was portioned between 
distilled water and ethyl acetate (EtOAc), yielding a water fraction (6.0 g) and EtOAc fraction (1.3 
g). The EtOAc portion underwent further fractionation by normal‐phase chromatography. The 
column was packed with 130 g of silica gel powder (Wakogel C‐300, Silica Gel, Wako Pure 
Chemical Industries, Osaka, Japan) and eluted with acetone/hexane (0%–100%). Fraction of 20% 
acetone was the active fraction (0.650 g), next subjected to the column chromatography of silica 
gel, which eluted with EtOAc/hexane (0%–100%) solvent. The active compounds (0.544 g; 20% 
EtOAc fraction) were subjected to silica gel column chromatography with elution solvents of 
51 
 
EtOAc/ hexane. The ratio of each solvent was adjusted to 3%, 5%, 8%, 11%, and 50% EtOAc in 
hexane. The volume of the eluent was set at 300 ml and fractions were collected into five 
subfractions (A, B, C, D, and E; all subfractions were set at 60 ml) for each eluent (Fig.3.1). The 
collected fractions were analyzed using thin‐layer chromatography (TLC silica gel 60 F254, EMD 
Millipore Corporation, Darmstadt, Germany) to detect the isolated compounds with anisaldehyde 
at 254 nm. Fractions that showed similar constituent spots were combined. 
 
3.2.5 Identification of the isolated compounds  
 All isolated compounds of the silica gel column chromatography with elution solvents of 
EtOAc/hexane were analyzed via 1H and 13C NMR spectra and recorded on a Bruker Avance 
(Bruker, Billerica, MA, USA) with CDCl3 using a 600 MHz spectrometer. Among them, fractions 
8A, 8C, and 11B contained a single compound. Fraction 8C was an aromatic compound; thus, 
further analysis was performed using GC/MS to obtain the molecular mass. Compounds 8A and 
11B were hypothesized to be fatty acids. To obtain more information about their molecular masses 
and formulas, GC/MS analysis was performed for both compounds after derivatization 
(methylation) with trimethylsilyl (TMS) diazomethane according to the method described by 
Presser and Hüfner (2004), with some modifications. One milligram of each compound was 
dissolved in a mixture of toluene– MeOH (1:2 v/v, 1 ml) and 100 μl of TMS diazomethane was 
added to the solution. The mixture was heated for 10 min at 80°C and subsequently dried in a 
nitrogen stream. Hexane (1 ml) was added to the residue, followed by extraction of 10 μl, which 
was diluted 100‐fold with the same solvent and analyzed by GC/MS (Shimadzu GCMSQP2010C, 
Kyoto, Japan). GC/MS analysis was performed using a DB‐23 column (thickness, 0.25 μm; length, 
30 m; and inner diameter, 0.25 mm). The oven temperature was 50°C and the mass range was m/z 
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40–800. The injection volume was 1 μl with 220°C as the injector port temperature. The following 
oven temperature program was carried out with helium (at a constant flow rate of 1 ml/min) as the 
carrier gas: 2 min at 50°C, increasing to 160°C at 15°C/min, and then to 220°C at a rate of 4°C/min. 
The interface and ion source were kept at 220°C and 200°C, respectively. All mass spectra were 
acquired in the electron impact mode. Ionization was off during the first 5 min to avoid solvent 
overloading and the mass range was m/z 40–800. Methylation followed by the GC/MS analysis 
was not suitable for the identification of compound 11B. 
 Therefore, further purification was performed using preparative TLC. About 5 mg of 11B was 
spotted onto TLC (Silica Gel 60 F254, EMD Millipore Corporation) and developed via 20% ethyl 
acetate in hexane. Subsequently, the edges of the plate were sprayed with anisaldehyde. Thereafter, 
the silica gel corresponding to the detected spots was collected by scratching. The compounds 
were extracted from the silica gel by the same solvent mixture. 
 Two subfractions were obtained and named B4 and B5 (Fig.3.2). B4 and B5 were analyzed by 
NMR and ESI mass spectroscopy. The ESI mass spectra were recorded using a Waters Quattro 
Micro mass spectrometer combined with a Waters Photodiode Array Ultra‐Performance Liquid 
Chromatography (UPLC) system in a positive mode. The mass range was m/z 200–800 and the 
column was an ACQUITY UPLC BEH C18 column (2.1 × 50 mm, 1.7 μm, Waters). The solvents 
were acetonitrile containing 0.1% formic acid and Milli‐Q containing 0.1% formic acid with 
gradient elution from 5% to 100% for 10 min. The flow rate was 0.2 ml/min and the column 
temperature was 40°C. The HRMS was recorded using an Exactive Mass Spectrometer (Thermo 












Fig.3.2 TLC detection of compounds B4 and B5  
 
3.2.6 Minimum inhibitory concentration of the isolates  
 The dried fractions were used to prepare a stock solution of 1 mg.mL-1. Each fraction was 
diluted directly in a microplate with a round bottom containing the hemagglutination assay reaction 
mixture to obtain a final concentration ranging from 100 to 1.6 μg/ml. The MIC was calculated 
from the lowest concentration of the fraction that completely inhibited the hemagglutination 
activity. The experiment was conducted in triplicate. 
 
3.3 Results 
 The inhibitory activity against hemagglutination of the crude aqueous extract of M. ciliatum 
seeds was evaluated at different concentrations (4.00–0.035 mg.mL-1). The crude extract of M. 
ciliatum revealed high anti‐hemagglutination activity with a MIC value of 0.07 mg.mL-1 (Fig.3.3). 
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To identify the compounds responsible for hemagglutination inhibition, several purification steps 
were performed as illustrated in Fig.3.1. Four compounds were isolated and identified as anti‐
hemagglutination agents (Fig.3.4). The physical and chemical characteristics of these compounds 
were as follows: Compound 8A (34 mg) was an amorphous colorless oily compound. The 
molecular weight of 8A was determined to be 282 on the basis of ESI‐MS (m/z 282.4 [M + H]+). 
The pure compound was methylated using TMS diazomethane and subjected to GC/MS analysis. 
We detected a single peak at Rt 16.2 min, and the peak showed the following spectrum: m/z 
(relative intensity %) 264 (25), 222 (8), 180 (10), 123 (10), 97 (50), 96 (49), 83 (51), 74 (52), 96 
(75), 55 (100), and 41 (70). A database search with NIST08 mass spectral library indicated that 
the methylation product from compound 8A was 9‐octadecenoic acid (Z)‐methyl ester, which is 
an oleic acid methyl ester. Thus, the original compound prior to methylation was thought to be 
oleic acid. To confirm this, the 1H NMR data (appendices figures S1-S4) of the isolated compound 
before methylation (Table 3.1) were compared with the data of authentic oleic acid (Wako Pure 
Chemical Industries, Osaka, Japan). The isolated compound 8A and oleic acid showed the same 
1H NMR spectrum proving that the isolated compound 8A was oleic acid (Fig.3.4B). Compound 
8C (100 mg) was a white powder with a pleasant aroma. We analyzed the compound by GC/MS. 
The analysis showed a single peak at Rt. 21.5 min. The mass spectrum of this peak was as follows: 
m/z (relative intensity %) 146 (100), 118 (89), 90 (36), 89 (35), and 63 (20). A database search 
with NIST08 Mass Spectral Library indicated that this compound is 5,6‐benzo‐α‐pyrone, 
otherwise known as coumarin (Fig.3.4A). The retention time of authentic coumarin (Wako Pure 
Chemical Industries) is the same as that of compound 8C, and the mass spectra are identical. The 
1H and 13C NMR data are shown in Table 3.1 and are identical to those of the authentic compound. 
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 Compounds B4 and B5 (2.4 and 1.7 mg) were colorless and amorphous. As shown in Table 3.2, 
the 1H NMR spectra of these compounds showed signals corresponding to oleic acid, but the 1H 
NMR signal corresponding to the carboxyl group was not detected. In the spectrum of B4, 
additional signals at δH4.20–4.19 ppm were detected, while in the spectrum of B5, signals at 
δH4.30–4.16 ppm were detected. The ESI mass spectra of compounds B4 and B5 were identical 
to each other and showed a sodium adduct ion at m/z 643.8 ([M + Na]+) (Fig.3.5), indicating that 
their molecular weights were 620. On the basis of these data, these compounds were considered to 
be 1,2‐dioleylglycerol and 1,3‐dioleylglycerol (Fig.3.4C, D). Fig.3.5 and Fig.3.6 show the 
comparisons of the ESI mass spectra and retention times of B4 and B5 on LC/MS analysis, 
respectively. The authentic 1,2‐dioleylglycerol and 1,3‐dioleylglycerol were used as standards. 
The results of 1H NMR spectra in Table 3.2 approved that the compounds B4 and B5 were 1,2‐
diolein and 1,3‐diolein. 
 
 
Fig.3.3 Inhibitory activity of M. ciliatum seeds' aqueous extract on P. gingivalis hemagglutinins. 
P.C and N.C are positive control and negative control, respectively. 
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3.3.1 The inhibitory activity of M. ciliatum and identified compounds  
 The purified and identified compounds (8A, 8C, B4, and B5) were first tested for the 
hemagglutination inhibitory activity using a reaction mixture containing the purified compounds 
at a final concentration of 100 μg/ml followed by assays with different dilutions (Table 3.3). The 
MIC was calculated from the last concentration that led to complete inhibition toward 
exohemagglutinin from P. gingivalis formed in planktonic cells from a broth culture. Oleic acid 
(8A) had higher inhibitory activity among the isolated compounds with a MIC value of 15 μg/ml 
followed by coumarin (8C), which showed inhibitory activity with a MIC value of 50 μg/ml. The 
diacylglycerols (B4 and B5) were less effective on P. gingivalis hemagglutinins than oleic acid 
and coumarin, and their MIC value was 100 μg/ml. However, 1,2‐dioleylgycerol (B4) showed 





Fig.3.4 Chemical structures of the isolated compounds: (A) Coumarin, (B) oleic acid, (C) 1,2‐









Table 3.1: 13C (150 MHz) and 1H (600 MHz) NMR data of compound 8A and 8C (CDCl3) 
Compound 8A Compound 8C 
δC δH (J=Hz) δC δH (J=Hz) 
179.54 1H, 10.69 m 160.68 1H, 7.71 d (9.54) 
130.01 2H, 5.34 m 154.03 1H, 7.52 ddd (8.6, 7.5,1.5) 
129.71 2H, 2.34 t (7.8) 143.35 1H, 7.48 dd (7.5, 1.5) 
34.05 4H, 2.00 m 131.79 1H, 7.32 d (8.6, 1.0) 
31.89 2H, 1.63 m 127.81 1H, 7.27 ddd (7.5, 7.5,1.0) 
29.67 20H, 1.34-1.26 m 124.36 1H, 6.42 d (9.54) 
29.42 3H, 0.88 t (7.2) 118.7  
29.16  116.83  
27.7  116.65  
24.8    
22.5    
14.05    
 
 
Table 3.2: 1H NMR data of compounds B4 and B5 (CDCl3, 600MHz) 
Compound B4 Compound B5 
δH (J=Hz) δH (J=Hz) 
4H, 5.38-5.31 m 4H, 5.35 m 
1H, 5.08 m 4H, 4.30 m 
2H, 4.20 m 1H, 4.16 m 
2H, 3.73 m 4H, 2.34 t (7.8) 
4H, 2.34 t (7.8) 8H, 2.04 m  
8H, 2.00 m 4H, 1.61-1.59 m 
40H, 1.38-1.25 m 40H, 1.38- 1.28 m 
1H, 1.2- 1.00 m 6H, 0.88 t (7.2) 


















Table 3.3: Hemagglutination inhibition activities of isolated and standard compounds 
Isolated  
compounds 




8C 50 Coumarin  100 
8A 15 Oleic acid  ≤15 
B4 ≤100 1,2-Diolein ≤100 
B5 100 1,3-Diolein 100 
 
 
3.1 Discussion and conclusion 
 Adhesion to the host's surface cells is a very important stage for mucosal virulent pathogens 
and enables them to survive and grow. Thus, prevention and remediation of their adherence might 
decrease and/ or impede bacterial colonization and subsequent tissue inflammation (Labrecque et 
al., 2006; Wittschier et al., 2009; Wittschier et al., 2007). Over the past decades, natural 
compounds with antibacterial and anti‐inflammatory properties have been identified as alternative 
and new therapeutic agents that might cure periodontal infections. For instance, several natural 
products and synthetic protease inhibitors have been used to block bacterial proteases; they have 
been proven to be effective by weakening bacterial adhesion and reducing proteolytic efficiency 
(Curtis et al., 2002; Kadowaki et al., 2004). It is well known that P. gingivalis cell adhesion 
predominantly relies on the functions of hemagglutinins; therefore, the use of antiadhesive 
compounds that influence the interaction between hemagglutinins and erythrocyte proteins could 
hinder periodontitis in the early stages (Miyachi et al., 2007; Yokoyama et al., 2007). Recently, 
63 
 
we evaluated a group of Sudanese medicinal plants against virulence factors. The aqueous extract 
of M. ciliatum seeds revealed potent anti‐hemagglutination activity (Eltigani et al., 2019). This 
plant has been reported by western Sudanese people as a natural pain killer for liver and stomach 
pains (Mariod et al., 2009). In addition, constituents of this plant have been shown to have 
anticytotoxic properties (Uguru and Evans, 2000). In our study, the main aim was to investigate 
the inhibitory activity of the aqueous extract of M. ciliatum seeds on hemagglutination by P. 
gingivalis and the related bioactive compounds. The crude aqueous extract of the seeds revealed 
high inhibitory activity against all exohemagglutinins existing in the broth culture, with a low MIC 
value of 0.07 mg.mL-1 (Fig.3.3). This result confirmed that the aqueous extract of M. ciliatum 
seeds has a significant influence on the exohemagglutinin function. The isolated compounds were 
identified as oleic acid, coumarin, 1,2‐dioleylglycerol, and 1,3‐dioleylglycerol (Fig.3.4). Though 
the presence of oleic acid and coumarins in several plant species has been reported by several 
researchers (Mariod et al., 2009; Rosselli et al., 2009; Spino et al., 1998), none so far have been 
isolated or purified, and these compounds have not been chemically identified in M. ciliatum. 
Furthermore, we found other two compounds claasified into diacylglycerols (1,2‐dioleylglycerol, 
and 1,3‐dioleylglycerol) from M. ciliatum. These compounds, which exist in several vegetable and 
seed oil, are well known for their functional roles in medicinal fields (AlAttas et al., 2016; Huang 
et al., 2011; Lopes et al., 2014). However, and to the best of our knowledge, these compounds are 
very rare in higher plants. Therefore, the identification and isolation of 1,2‐ and 1,3‐
dioleylglycerols from M. ciliatum will be a convenient and cost‐effective source of these bioactive 
compounds for therapeutic use, especially for people in arid and semi‐arid lands. The fraction 11B, 
which was isolated from the silica gel column with 11% EtOAc/hexane, was analyzed by 1H NMR, 
and it was thought that it might contain more than one compound. Further purification using TLC 
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revealed two main compounds as illustrated in Fig.3.2. The mass spectrum of both purified 
compounds was 643.8 m/z [M + H]+, with the chemical formula C39H72O5 (Fig.3.4), which 
hinted at the similarity between the two purified compounds. The δH 3.72 ppm, 5.08 ppm and the 
multiple shapes of the chemical shift between 4.20 and 4.19 ppm (Table 3.3) described the 
corresponding esterified glycerol with the 1,2-diglyceride position. Moreover, the signal 4.08–4.21 
ppm of another compound revealed 1,3‐diglycerol (Nieva‐Echevarría et al., 2015). Further 
confirmation was obtained using a mass chromatogram of isolated and purchase standard 
compounds (Fig.3.5 and Fig.3.6). The retention times were similar between B4 and 1,2‐
dioleylglycerol and B5 and 1,3‐dioleylglycerol. 
 The current study showed that isolated oleic acid has inhibitory activity with a MIC value of 15 
μg/ml, while 1,2‐ and 1,3‐dioleylglycerols showed weaker inhibitory activities with a MIC value 
of 100 μg/ml (Table 3.3). These results agree with the findings of Huang et al. (2011). Their group 
found some correlation between the antimicrobial activities of fatty acids and their structure, and 
that the modification of the fatty acid carboxyl group might significantly influence the inhibitory 
activities. Commonly, fatty acids strongly inhibits oral bacterial growth compared with their esters. 
One hypothesis suggests that fatty acids and their esters might penetrate the cell wall of the 
bacterial membrane because they are bipolar and both have a hydrophilic head and hydrophobic 
tail (Huang et al., 2011). The n‐6, n‐7, and n‐9 fatty acids were reported to have antimicrobial 
activity higher than the esters against periodontopathogens Actinobacillus 
actinomycetemcomitans and P. gingivalis. Moreover, the inhibitory activity of isolated 
compounds might influence protein structures through oxidation and the formation of ester bonds 
between aggregating proteins and inhibitor compounds, or by covalent binding and protein 
aggregation (Inoshita et al., 1986). Coumarins are phenolic compounds that are renowned as 
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potential therapeutic agents for treating periodontal disease. These compounds have been reported 
for their ability to inhibit P. gingivalis growth and MMP‐9 collagenase (Marquis et al., 2012). In 
this study, the isolated coumarin inhibited P. gingivalis hemagglutinins, which are vital adherence 
molecules for iron and heme uptake via attachment, aggregation, and lysis of erythrocytes (Gao et 
al., 2010; Smalley et al., 2011). Some reports have shown that coumarins possess iron‐chelating 
properties (Mladenka et al., 2010). Therefore, the inhibition activity of the isolated coumarin might 
be related to the chelation of iron in the reaction mixture, which then made iron unavailable for 
virulence factors. In conclusion, in recent decades, plants with a pleasant aroma and 
pharmaceutically bioactive compounds have received increasing attention as potent sources for the 
reformation of different foods and pharmaceutical products. The inhibition of P. gingivalis 
hemagglutinin using the aqueous extract of M. ciliatum seeds, which has a very pleasant aroma 
and contains valuable compounds associated with oral hygiene, supports the further therapeutic 








CHAPTER FOUR  




 Porphyromonas gingivalis is an anaerobic gram-negative, asaccharolytic bacterium associated 
with periodontitis (Isogai et al., 1988). This bacterium grows faster in medium supplemented with 
hemin, via adherence and agglutination of human erythrocytes to get heme molecules and amino 
acids as nutrients (Sakai et al., 2007). P. gingivalis produces putative virulence-associated with 
adherence and colonization, including fimbriae, lipopolysaccharides, proteases like gingipains, 
and potential adhesion molecules such as hemagglutinins, all of which are known as virulence 
factors (Connolly et al., 2017). The most important virulence factors that P. gingivalis produces 
are the hemagglutinins (Han et al., 1996; Lee et al., 1996; Shi et al., 1999). This group of proteins 
is considered to be the important protein of this bacteria, facilitating the adherence to host cells 
and accelerates the growth of this bacterium (Okuda et al., 1986). Following the adhesion process, 
gingipains proteins act mainly to aquacise the heme from erythrocytes to feed P. gingivalis and 
maturate other virulence. Gingipains are cysteine proteinases which encoded by three genes 
gingipain R1 (RgpA), gingipain R2 (RgpB), and gingipain K (Kgp). These proteins are consisting 
of propeptide, catalytic and C-terminal hemagglutinin/ adhesion domains (Genco et al., 1999). 
Therefore, the development of anti-adhesive compounds against P. gingivalis hemagglutinins 
could be a promising cytoprotective strategy to prevent the harmful effects of long-term bacterial 
infection (Cutler et al., 1995).  
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 Numerous fatty acids have been isolated from animals, plants, and microorganisms with several 
biological functions such as antifungal, antibacterial, and anticancer (Yoon et al., 2018; Jóźwiak 
et al., 2020; Engelking, 2010). Furthermore, several studies approved the antibacterial and 
antiadhesion properties of the fatty acids from natural or artificial sources against oral pathogens, 
including P. gingivalis (Huang et al., 2011; Pan et al., 2019; Sulijaya et al., 2019; Johnson et al., 
2014). Nonetheless, to date, there is no study investigating the influence of the fatty acids on the 
most aggressive P. gingivalis strain TDC60 and its exo-hemagglutinins and the other related 
protein involved in the pathogenicity event. Recently, we isolated oleic acid and its esters from 
Sudanese folkloric medicinal plant with inhibitory activity to P. gingivalis exo-hemagglutinins 
(Eltigani et al., 2019). Therefore, in this study, we investigated the influence of different fatty acids 
with various carbon chain-lengths and saturation degrees on hemagglutination and gingipains of 
P. gingivalis TDC60 using the sub-minimum inhibitory concentration model.  
 
4.2 Materials and methods  
4.2.1 Preparation of fatty acids stock solutions 
 Arachidic acid, arachidonic acid, decenoic acid, neo decanoic acid, oleic acid, linoleic acid, 
linolenic acid, and stearic acid were obtained from Sigma-Aldrich Japan (Tokyo, Japan). 2- 
Hexadecenoic acid was purchased from TCI (Tokyo Chemical Industry Co. Ltd.). Palmitic acid 
was obtained from Fujifilm Wako Pure Chemical Corporation (Osaka, Japan). A stock solution of 






4.2.2 Cultivation of P. gingivalis 
 As described previously in chapter two, the bacterium was grown in Tryptic Soy Blood Agar 
medium supplemented with hemin (5 mg.L-1), menadione (1 mg.L-1), and horse blood at 37°C 
under anaerobic conditions for five days (Gao et al., 2010; Rangarajan et al., 2017). Followed by 
inoculation of the cells into 5 mL of Gifu Anaerobic Medium (GAM broth medium) and incubated 
under anaerobic conditions at 37°C for three days. The growth rate was evaluated using a 
spectrophotometer at 600 nm, and the cells were removed by centrifugation. The collected culture 
supernatant (Pg-sup) was used for the inhibition assays. 
 
4.2.3 P. gingivalis growth inhibition 
 The influence of the long-chain fatty acids solution on P. gingivalis growth was investigated by 
measuring the turbidity of bacterial suspension in a 96-well microplate. Two microliters of fatty 
acids (1 mg.mL-1) were added to 200 μL of P. gingivalis suspension standardized at 2 x107 CFU 
(Kariu et al., 2017). The plates were incubated anaerobically at 37°C for 60 h. Then the turbidity 
was measured at 600 nm using a microtiter plate reader (Model 680, Bio-Rad Laboratories Inc., 
Hercules, CA, USA). The positive control was designed as P. gingivalis, and negative control was 
the GAM broth medium, without fatty acids solutions. 
 
4.2.4 Inhibition of hemagglutination 
 Hemagglutination or erythrocyte aggregation was performed as described previously in chapter 
two. In a 96-well microtiter plate (round bottom) using a reaction mixture consisting of 80 μL of 
PBS, 10 μL of Pg-sup, and 10 µL of fatty acids solutions. The mixture was shaken carefully then 
incubated for 10 min at room temperature. Next, 100 μL of 5% blood was added to the assay 
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mixture. Hemagglutination was evaluated visually after 2 h of incubation at room temperature. 
PBS was used instead of Pg-sup and fatty acids solutions for a negative control. The minimum 
inhibitory concentration was calculated from the final concentration of the lowest dilution with 
complete inhibitory activity. 
 
4.2.5 Identification of exo-hemagglutinins secreted by P. gingivalis 
 Proteins secreted into P. gingivalis culture supernatants were sampled after 30h of anaerobic 
cultivation. Hemagglutinins were partially purified using ammonium sulfate precipitation at a 
concentration of 80%. The partially purified proteins were analyzed using a 15% SDS-PAGE 
under denaturing conditions or by zymography and stained with Coomassie Brilliant Blue (CBB). 
The N-terminals of partially purified proteins were identified by blotting the proteins onto a 
polyvinylidene fluoride membrane. The membrane was stained with CBB stain, and the bands 
were excised, then the N-terminal amino acid sequences were determined by automated Edman's 
degradation method using Shimadzu PPSQ-31A Protein Sequencer (Shimadzu 190 Corporation, 
Kyoto, Japan). The N-terminal sequences of individual protein were searched against the non-
redundant NCBI database using the BLAST program (http://www.ncbi.nlm.nih.gov/BLAST) to 
identify hemagglutinins proteins. 
 
4.2.6 Influence of fatty acids sub-MICs on hemagglutinins secretion  
 Effect of fatty acids sub-MICs on hemagglutinins induction was investigated according to the 
method mentioned by Kan et al. (2019), by minor amendments. Antibacterial activities of the 
unsaturated fatty acids on P. gingivalis were determined using final concentration equivalent to 1/2, 
1/4, and 
1/8 of identified MIC value for each fatty acid. The sub-MICs for 2- hexadecenoic and 
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linolenic acids were prepared in the concentrations of 2.5 μg. mL-1 (1/2), 1.3 μg. mL
-1 (1/4) and 0.6 
μg. mL-1 (1/8). Oleic, linoleic and arachidonic sub-MICs were prepared with concentrations of 1.3 
μg.mL-1 (1/2), 0.6 μg.mL
-1 (1/4) and 0.3 μg.mL
-1 (1/8). The samples anaerobically incubated at 37°C 
in GAM broth media. After 30 hrs, the culture supernatant and cells of P. gingivalis were separated 
by centrifugation at 8000xg for 20 min at 4°C. Supernatants were partially purified using 
ammonium sulfate at a concentration of 80%. Hemagglutination activity of partially purified 
proteins was evaluated, and the induction of hemagglutinins was analyzed SDS-PAGE using 8 µg 
protein. The collected cells were weighted, and identical weight was suspended in 0.5 M Tris-HCl 
buffer (pH 7.6), then sonicated for 3 min on ice to be used for protease activity analysis. 
 
4.2.7 Protease inhibition 
 Gingipains activities of P. gingivalis cells preincubated with unsaturated fatty acids at different 
concentration of sub-MICs was determined as stated previously (chapter two) with some changes. 
Gingipains activities were assayed using t-butyloxycarbonyl-L-valyl-L-prolyl-L-arginine-4-
methylcoumaryl-7-amide (Boc-VPR-MCA), and t-butyloxycarbonyl-l-valyl‐l‐leucyl‐l‐lysine-4-
methylcoumaryl-7-amide (Boc‐VLK‐MCA) was adopted as a protease substrate for Rgp and Kgp, 
respectively. Ten microliters of P. gingivalis cell-free extract were added into the mixture 
containing 40 μL of 0.5 M Tris-HCl buffer (pH 7.6) and 40 μL of distilled water containing 5 mM 
of L-cystein. After 5 min preincubation at 37°C, 10 μL of 500 μM Boc-VPR-MCA or Boc-VLK-
MCA was added to the mixture. The release of amino methyl-coumarin was measured with an 
excitation at 380 nm and emission at 440 nm using a fluorescence spectrophotometer (Infinite M 
200 Pro, TECAN, Männedorf, Switzerland, Japan). The linear increase of amino methyl-coumarin 
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4.3.1 The in-vitro inhibition of P. gingivalis and exo-hemagglutinins 
 In this study, ten fatty acids were selected with a varied carbon chain length, between ten to 
twenty, and different in its saturation degrees, to compare its inhibitory activity against 
P.gingivalis TDC60 planktonic cells and its exo-hemagglutinins exists in the culture supernatant 
using an in vitro experiment model. The results of P. gingivalis growth inhibition and inactivation 
of hemagglutinins of fatty acids are presented in Table 4.1. The fatty acids can be separated into 
four groups based on their chain length. The first group contains neodecanoic acid and decenoic 
acid with 10 carbons saturated and unsaturated, respectively. Both fatty acids could not inhibit the 
growth of P. gingivalis, while decenoic acid had a very weak inhibitory activity to the 
hemagglutinins with MIC at >100 µg.mL-1. Palmitic and 2- hexadecenoic acids, which represented 
the second group with 16 carbons, suppressed the bacterial growth and hemagglutinins. However, 
the unsaturated fatty acid, 2- hexadecenoic acid, exhibited low MIC values for both tested 
parameters compared to that of saturated fatty acid. A similar trend was observed in the third group, 
which comprises four fatty acids with different degrees of saturation named stearic, oleic, linoleic, 
and linolenic acids with 18 carbon atoms. The unsaturated fatty acids showed very potent 
inhibitory activity against bacterial and hemagglutination with MICs values ranged from 2.5 – 6.3 
µg.mL-1, while the stearic acid, a saturated fatty acid, displayed a moderate influence against the 
hemagglutination with no antibacterial activity on P. gingivalis. The last group of selected fatty 
acids covering the 20 carbons fatty acids, a clear variation between saturated and unsaturated fatty 
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acids was observed. Only arachidonic acid, unsaturated fatty acid, exhibited an effective inhibitory 
activity against P. gingivalis growth and hemagglutination. Based on the accumulated data of MIC 
values for saturated and unsaturated fatty acids with different carbon chain lengths, unsaturated 
fatty acids were found to have a potent inhibitory activity compared to saturated fatty acids. 
Therefore, unsaturated fatty acids were selected to investigate its influence on the production of 
the virulence factors at sub-MICs concentrations. 
 
4.3.1 Effects of sub-MICs of unsaturated fatty acids on P. gingivalis pathogenicity 
 The impact of sub-MICs concentrations of unsaturated fatty acids on P. gingivalis cell 
proliferation and production of exo-hemagglutinins (Fig.4.1A and B)., Except linolenic acid, all 
unsaturated fatty acids powerfully impeded the cell proliferation (<5%) and hindered 
hemagglutinin production at a sub-MIC concentration equivalent to ½ of MIC. The reduction of 
unsaturated fatty acids concentration to ¼ of MIC revealed fluctuated effects on bacterial growth 
and hemagglutinin secretion.  Linoleic and arachidonic acid retained its ability to inhibit bacterial 
growth to <15% and totally inhibited hemagglutinins. A moderate bacterial growth was observed 
in the existence of oleic and linolenic acid compared to that of 2- hexadecenoic acid, in which no 
inhibition activity was observed at a concentration equal to ¼ of its MIC value. However, oleic 
acid and 2- hexadecenoic acid were inhibited hemagglutinins at a concentration corresponding to 
¼ MIC but not linolenic acid. In the lowest concertation (1/8 of MIC), there was no influence on 
neither cell proliferation nor hemagglutinin in the addition of  oleic acid, linolenic acid, and 2- 
hexadecenoic acid. However, linoleic acid and arachidonic acid were inhibited hemagglutinin 








 The correlation between the cell proliferation and hemagglutinin production was confirmed by 
SDS-PAGE (Fig.4.1C) after partial purification using 80% ammonium sulfate of the exo-
hemagglutinins in the culture supernatant. There were several bands detected in the positive 
control sample (P. gingivallis only), and similar bands were observed in the samples pre-incubated 
with the lowest concentration of unsaturated fatty acids or that of active hemagglutinin. These 
bands were disappeared or weaken in the samples exposed active hemagglutinin. The main bands 
Fatty acid  Degree of saturation 
Growth inhibition Hemagglutinin inhibition  
MIC (μg. mL-1) 
Neo decanoic acid 10:0 ND ND 
Decenoic acid 10:1 ND >100 
Palmitic acid 16:0 50 13 
2- hexadecenoic acid 16:1 >5 ≤ 6.3 
Stearic acid 18:0 ND 25 
Oleic acid 18:1 2.5 ˃6.3 
Linoleic acid 18:2 2.5 ˃ 6.3 
Linolenic acid 18:3 5 6.3 
Arachidic acid 20:0 ND ND 
Arachidonic acid 20:4 2.5 6.3 
75 
 
that might be important for the erythrocyte aggregation and detected in all samples with high 
hemagglutination activity were around 72.3 kDa, 53.8 kDa, 46.4 kDa, and 43.5 kDa proteins, in 
addition to 19.1 and 18.5 kDa. 
 
Fig.4.1 The influence of unsaturated fatty acids sub-MICs on P. gingivalis and its 
hemagglutination. A: inhibition of P. gingivalis proliferation. B: hemagglutination inactivation by 
unsaturated fatty acids sub-MICs. C: SDS-PAGE of hemagglutinin related proteins 
 
4.3.3 Identification and molecular morphology of proteins with hemagglutination activity 
 To analyze partially purified hemagglutinations, N-terminal amino acid sequence analysis was 
performed for the entire bands appear in the SDS-PAGE of partially purified protein following 
80% ammonium sulfate precipitation (Fig.4.2). The resulting N-terminal sequences were 
compared with those in the protein database using NCBI-BLAST program via NCBI webservers.  
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As presented in Fig.4.3, three protein sequences have multiple hemagglutinin related domains, and 
many repetitive sequences were observed as closest proteins. The 72.3 kDa and 53.8 kDa proteins 
showed homology to the middle sequence of the hemagglutinin domain in gingipain R1 
hemagglutinin and Lys-gingipain protease. Meanwhile, the 46.4 kDa and 43.5 kDa proteins 
showed similar homology to the middle sequence of gingipain R1 hemagglutinin. The 19.1 kDa 
and 18.5 kDa proteins showed high homology to the middle sequence of the hemagglutinin domain, 




Fig.4.2 N-terminal amino acid sequence of the partially purified protein using 80% ammonium 
sulfate, bands appear in the SDS-PAGE were compared with those in the protein database using 




Fig.4.3 Sequence diagram of three proteins deduced from the N-terminal amino acid analysis of 
hemagglutinins related proteins.  
 
4.3.4 Effects of sub-MICs of unsaturated fatty acids on P. gingivalis gingipains 
 The expression of gingipain R (Rgp) and gingipain K (Kgp) of P. gingivalis cell preincubated 
with sub-MICs concentrations of unsaturated fatty acid was determined and displays in Fig.4.4. 
Oleic and arachidonic acids blocked both Rgp and Kgp at entirely sub-MICs concentrations. A 
similar effect was obtained with linolenic and 2- hexadecenoic acids, which revealed a significant 
effect on gingipain R and K expression at 1/2 and 
1/4 sub-MIC concentrations. In contrast, at 
1/8 
sub-MIC concentration, linolenic acid suppressed 50% of Kgp and 80% of Rgp, while the same 
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level of 2- hexadecenoic acids was not impeded the gingipains of P. gingivalis. The unsaturated 
fatty acid linoleic acids showed a moderate influence on the gingipains activity at all sub-MIC 




Fig.4.4 Impact of unsaturated fatty acids sub-MICs on P. gingivalis on gingipain R (Rgp) and 
gingipain K (Kgp), after the pre-incubation with unsaturated fatty acids sub-MICs 
 
4.1 Discussion and conclusion 
 Hemagglutinins and gingipains protease are the main virulence factors of P. gingivalis for 
proliferation, colonization, and adherence to the host cells (Lewis et al., 2006; Olczak et al., 2008). 
Hemagglutinins are a large class of proteins that play a crucial role in nutrient acquisition and 
facilitation of erythrocyte binding following by absorption of heme, which has special significance 
because heme accelerates the growth of this bacterium (Sakai et al., 2007). Then allows the 
proteolytic gingipains to release the heme moiety from the hemoglobin molecule via the dual-
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component uptake system HmuY/HmuR (Lewis et al., 2006; Olczak et al., 2008). Consequently, 
blocking these virulence factors might reduce and obstruct bacterial colonization and subsequent 
tissue inflammation (Labrecque et al., 2006; Wittschier et al., 2009; Wittschier et al., 2007). The 
antibacterial activity of the fatty acids has been reported against several oral pathogens including 
P. gingivalis (Sulijaya et al., 2019; Choi et al., 2013; Huang et al., 2011), but no study has been 
conducted to evaluate the impact of fatty acids on hemagglutinins and other virulence factors. 
Recently, we isolated oleic acid and its esters glycerols with inhibitory activity on P. gingivalis 
exo-hemagglutinins (Eltigani et al., 2019). Thus, in this study, we aimed to explore the 
antimicrobial and anti-hemagglutination of various long-chain fatty acids and saturation degrees 
and the expression of the proteins involved in hemagglutinating action by P. gingivalis. The in 
vitro impact of selected long-chain saturated and unsaturated fatty acids, with different carbon 
chain length, on P. gingivalis TDC60 strain and its outer cell membrane hemagglutinins illustrated 
in Table 4.1.  The results revealed that unsaturated fatty acids exhibited high suppression of P. 
gingivalis proliferation in GAM broth media with MIC range from 5 to 2.5 μg.mL-1 compared to 
that of saturated fatty acids. However, palmitic acid, a saturated fatty acid, showed moderate 
antibacterial activity at MIC 50 μg.mL-1. This result agrees with the previously reported finding of 
Huang et al. (2011) and Choi et al. (2013), who found antibacterial activity from palmitic, oleic, 
linoleic, and arachidonic acids on P. gingivalis ATCC 33277 and 381.  P. gingivalis TDC60 strain 
was found to be more aggressive in the pathogenicity than the other periodontal pathogenic 
bacteria such as P. gingivalis ATCC 33277 and 381 strains (Watanabe et al., 2011). Therefore, the 
current results will expand the knowledge on the function of long-chain fatty acid, particularly 
against the most aggressive strain that has been identified so far. The antibacterial activity of long-
chain unsaturated fatty acids has been well-known as one of its properties for many years, 
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including oleic acid, linoleic acid, and linolenic acid, while long-chain saturated fatty acids, 
including palmitic acid and stearic acid, are reported as showing less antibacterial activity (Sun et 
al., 2003; Seidel and Taylor, 2004). In addition to cell growth and proliferation, P. gingivalis 
pathogen has several vital virulences such as hemagglutinins, which support the adhesion of 
bacterium to the host erythrocytes to obtain the nutrients like heme and amino acids. Hence, the 
use of antiadhesive materials to block the interaction between hemagglutinins and erythrocyte 
proteins could be one of the potent strategies to hamper periodontitis progression in the early stages 
(Miyachi et al., 2007; Yokoyama et al., 2007).  
 Concerning hemagglutinins inhibition, both saturated and unsaturated fatty acids revealed anti-
aggregation of the erythrocytes in the in-vitro assay. Nonetheless, the longer unsaturated fatty acids 
had lower MIC values. Lately, unsaturated long-chain fatty acids gain important characteristics as 
anti-adhesive and antibiofilm formation beside their antimicrobial activity. This action is supposed 
to be related to the unsaturated form of the fatty acids and their physicochemical properties, which 
might reduce the adhesive work of P. gingivalis and control the progression of periodontitis 
(Sulijaya et al., 2019; Pan et al., 2019). On the other hand, many studies mentioned that outer cell 
membrane virulence factors have independent action in the inflammation process from cellular 
activities of P. gingivalis and suppression of bacterial growth does not require inhibition of other 
virulence factors productivity (Olsen and Potempa, 2014; Blankenvoorde et al., 1998). However, 
P. gingivalis secretes all these virulence factors to acquire nutrients from the surrounding 
environment. On those bases, the sub-MICs of unsaturated fatty acids suppressed bacterial growth 
has been studied for inactivation of hemagglutinins and gingipain secretion in different dosage 
manner equivalent to 1/2, 
1/4 and 
1/8 of MICs values. The sub-MICs of unsaturated fatty acids 
decreased P. gingivalis growth (Fig.4.1A) through the inactivation of hemagglutinating related 
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proteins (Fig.4.1B). The influence of the unsaturated fatty acids on hemagglutination inhibition 
was confirmed by SDS page of the partially purified hemagglutinin containing sample (Fig.4.1C). 
Comprehensive analysis of the N-terminal amino acids of all bands of partially purified 
hemagglutinin secreted outside the cells revealed that six bands were proteins with a hemagglutinin 
domain. These proteins were derived from the translation products of three protein genes named 
gingipain R1 hemagglutinin, Lys gingipain protease, and hemagglutinin. The structure of these 
genes contains, in general, a propeptidase C25 sequence followed by a peptidase family C25 and 
several cleaved adhesin domains (Fig.4.3), which are well known through their function in 
bacterial cell adhesion (Li et al., 2010). The analyzed proteins equivalent to the band at, 46, 43, 
72, 53, 18, and 19 kDa proteins were detected in activated and non-inactivated P. gingivalis 
hemagglutinin, confirming the influence of sub-MICs of unsaturated fatty acids on the synthesis 
process of hemagglutinins related proteins. 
Interestingly, no band was detected on the native page of partially purified hemagglutinins (data 
not shown). The result was indicating that the hemagglutinin related proteins might construct a 
complex to perform aggregation functions. Since the N-terminal analysis revealed three genes 
possess proteases in addition to several cleaved parts.  
 This result pointed out the crucial role of gingipains and hemagglutinin for hemagglutination 
process. A similar finding was reported by Genco et al. (1999), who found that inactivation of 
gingipains R in the initial phase of the infection resulted in a weakening of P. gingivalis virulence 
in a mice experimental model. As well as Lys-gingipain protease, which implicated with Arg-
gingipain protease and hemagglutinin/ adhesion domain in targeting host biological substrates for 
adhesive functions (Li et al., 2011). The expression of these proteases was influenced by the Sub-
MICs of unsaturated fatty acids (Fig.4.2). Almost all unsaturated fatty acids inactivate both Kgp 
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and Rgp in the same means with antibacterial, and hemagglutination inhibition except linoleic acid 
showed similar reduction to Kgp and Rgp at all concentration dosages. 
 Inhibition of gingipains in the cellular protein of P. gingivalis supports our primary hypothesis 
that sub MIC of fatty acid significantly reduced the expression of related proteins. The current 
finding proposed that double-bond structure or double-bond position and length of the carbon 
chain are keys for fatty acids interaction with P. gingivalis proteins. However, several hypotheses 
suggested more than one theory for protein-fatty acids interaction, such as, that the hydrocarbon 
chain interacts primarily with hydrophobic residues of the protein. Additional view hypothesized 
that influence initiated through the interaction of the fatty acid carboxyl with basic amino acid 
residues of the bacterium proteins (Hamilton, 2002). Accordingly, we attempted to compare the 
same carbon number of the fatty acids (C10, C16, C18, and C20), and different in the presence of 
double-bond structure to inactivate hemagglutination action. Nevertheless, the mechanism of long-
chain fatty acid interaction and inhibition on P. gingivalis hemagglutinins is still not clear and 
additional studies are required. However, the fatty acid affinity or to the multiple heterogeneous 
binding sites for each specific fatty acid; by close interaction of carboxylic group with the basic 
amino acid residue of the proteins through the H-bonded in their side chain (Hamilton, 2002). 
 In conclusion, the current study investigated the influence of saturated and non-saturated fatty 
acids with middle and long carbon chains against P. gingivalis growth and hemagglutinins. The 
long-chain unsaturated fatty acids exhibited high inhibitory activity compared to that of saturated 
fatty acids. Furthermore, the sub-MIC dosages of unsaturated fatty acids surprised secretion of 
hemagglutinin and gingipains of P. gingivalis TDC60. Therefore, the results presented here will 
expand the uses of fatty acids to impede the undesired microbes. Moreover, most of the selected 
fatty acids found abundantly in the natural products. Therefore, it is safe additive agents, especially 
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with the low MIC values level required for the inhibition process. The mode of action of these 
fatty acids against virulence factors, is not clear yet, more studies will be done to analyze the 










Argeloside I a candidate hostile to pathogenicity of Porphyromonas gingivalis TDC60 
5.1 Introduction 
 Periodontal diseases are chronic inflammatory diseases of tooth-supporting tissues which 
weaken these tissues and lead to tooth loss (Huq et al., 2013; Haffajee et al., 2013). Among 
bacterial pathogens, Porphyromonas gingivalis has recently proposed to be a major pathogen that 
causes destructive periodontal diseases (Haffajee et al., 2013). This bacterium adheres to host 
tissues to obtain nutrients for growth. The degradation of host proteins and accretion of dental 
plaque enables this bacterium to survive and produce virulence factors (Beck et al., 2013; 
DeStefano et al., 2013). The main virulence factors in the primary stage of pathogenicity are 
hemagglutinins and gingipains located on cell surfaces and on vesicles (Holt and Bramanti, 2013; 
O'Brien-Simpson et al., 2001). Hemagglutinins are a group of proteins that allow P. gingivalis to 
adhere to the surfaces of host cells to facilitate the acquisition of heme through erythrocyte binding, 
causing the lysis and aggregation of erythrocytes via several cysteine proteinases known 
collectively as gingipains (Curtis et al., 1999; Bhogal et al., 1997). Gingipains are mainly Arg–
specific gingipains (Rgp) and Lys–specific gingipains (Kgp) and are also located in the outer cell 
membrane (Holt and Bramanti, 2013; O'Brien-Simpson et al., 2001). They play important roles in 
the acquisition and storage of the essential micronutrient iron and release the heme moiety from 
hemoglobin as a nutrient (Lewis et al., 2006; Olczak et al., 2008). Several strains of P. gingivalis 
have been identified (Watanabe et al., 2011; Naito et al., 2001; Nelson et al., 2003). We focused 
on the TDC60 strain to screen for compounds capable of inhibiting the pathogenicity of P. 
gingivalis as this strain was isolated from a severe periodontal lesion and its complete genomic 
86 
 
sequence is available (Watanabe et al., 2011). Strain TDC60 is more highly pathogenicity than 
other strains and cause severe abscesses in mice. We hypothesized that inhibition of the growth of 
TDC60 and/or its virulence factors might inhibit the growth of all P. gingivalis strains, thereby 
providing a cure for periodontal disease. The pathogenicity of the TDC60 strain has not been 
thoroughly investigated, despite its importance. 
 The therapeutic effects of a wide range of plant secondary metabolites, such as alkaloids, 
polysaccharides, glycosides, phenolic compounds, and sterols (Rahul et al., 2019), have been 
reported. Several studies have reported the specific inhibitory activities of polyphenolic 
compounds from green tea and cranberry against P. gingivalis and its secreted virulence factors 
(Feghali et al., 2012; Kushiyama et al., 2009). Moreover, oleic acid and its esters, together with 
coumarins from Monechma ciliatum seeds, have been reported as hemagglutinin inhibitors 
(Eltigani et al., 2019). We previously attempted to inhibit the growth of P. gingivalis TDC60 strain 
using aqueous extracts of Sudanese medicinal plants and found that Solenostemma argel leaf 
extracts potently inhibit P. gingivalis TDC60 (Eltigani et al., 2019).  
 Solenostemma argel, belongs to the family Apocynaceae and is widely grown in northern Africa, 
including Sudan, Egypt, Libya, and Algeria (Orange, 1982; Ahmed, 2004). In Sudan, S. argel is 
an important traditional medicine and is locally known as ‘hargel’ (Orange, 1982). The plant is 
widely distributed between Dongola and Barber, mainly around the Abu-Hamad area (Sulieman 
et al., 2009; Teia, 2018). S. argel leaf extract is used to make popular drink in Sudan.  It is also 
used in traditional medicine to treat several diseases, including liver and kidney pain, bronchitis, 
neuralgia, gastrointestinal cramps, and stomach colic. The dry leaves are used as incense to treat 
measles and aid wound healing (Orange, 1982; Sulieman et al., 2009; Kamel et al., 1982; Hassan 
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et al., 2001). Several studies have reported that S. argel leaves contain various compounds such as 
quercetin, rutin, flavanones, alkaloids, flavonoids, and kaempferol (Tigani. and Ahmed, 2009; 
Shafek and Michael, 2012). In the present study, we isolated a compound that exhibits inhibitory 
activity against P. gingivalis TDC60 and its virulence factors from aqueous extracts of S. argel. 
 
5.2 Materials and methods 
5.2.1 Aqueous extraction of leaves 
 Solenostemma argel leaves were obtained in Khartoum, Sudan. The leaves were authenticated 
at the Faculty of Agriculture, University of Khartoum. Soluble compounds were extracted twice 
with distilled water from cleaned and powdered leaves (1 g sample: 10 mL water) for 30 min at 
room temperature with slow shaking. The supernatants were collected by filtration followed by 
centrifugation and lyophilization. The stock solution was prepared from the dried extract in 
distilled water at a concentration of 100 mg·mL-1, followed by filtration using sterilization filters 
(MILLEX® GV 0.22 μm; Merk Millipore Ltd., Burlington, MA). The filtered stock was stored at 
–20 °C until analysis. 
 
5.2.2 Cultivation of P. gingivalis 
 Porphyromonas gingivalis TDC60 (Watanabe et al., 2011) was provided by the RIKEN 
BioResource Center through the National Bio-Resource Project of the Ministry of Education, 
Culture, Sports, Science and Technology, Japan. The bacterium was grown in tryptic soy blood 
agar medium (Agar Base EH) supplemented with hemin (5 mg·L-1), menadione (1 mg·L-1), and 
horse blood at 37°C under anaerobic conditions for 4–5 days (Gao et al., 2010; Rangarajan et al., 
2017). The cells were then inoculated into 5 mL of Gifu anaerobic medium (GAM broth medium) 
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(Umemoto et al., 1996) and incubated under anaerobic conditions at 37°C for 2–3 days until the 
middle stationary phase of bacterial growth. The growth rate was evaluated at 600 nm using 
spectrophotometer. The cells were harvested by centrifugation and the culture supernatant (Pg-
sup) was used for inhibition assays. 
 
5.2.3 P. gingivalis growth inhibition 
 The influence of S. argel leaf aqueous extract on P. gingivalis growth was investigated by 
measuring the turbidities of bacterial suspensions in a 96-well microplate. Ten microliters of plant 
extract (10 mg·mL-1) was added to 200 µL of P. gingivalis suspension standardized at 2 x107 CFU 
(Kariu et al., 2017). The plates were incubated anaerobically at 37°C for 60 h. The turbidity was 
then measured at 600 nm using a microtiter plate reader (Model 680; Bio-Rad Laboratories Inc., 
Hercules, CA).  
 
5.2.4 Hemagglutination assay  
 Erythrocyte aggregation was performed as described by Saiki and Konishi (Saiki and Konishi, 
2007) with slight modifications. Horse defibrinated blood (Cosmo Bio Co., Ltd., Tokyo, Japan) 
was rinsed three times with phosphate buffer saline (PBS) using a pipette prior to centrifugation 
for 5 min at 2,000 ×g. The washed erythrocytes were diluted to 5% (v/v) with PBS and used for 
the hemagglutination assay. The hemagglutination test was performed in a 96 well microtiter plate 
(round bottom) using a reaction mixture consisting of 80 µL PBS, 10 µL Pg‐sup, and 10 µL 
inhibitory compound. The mixture was shaken thoroughly and incubated for 10 min at room 
temperature, after which 100 µL 5% blood was added to the assay mixture. Hemagglutination was 
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evaluated visually after incubation at room temperature for 2 h. PBS was used instead of Pg‐sup 
as a negative control.  
 
5.2.5 Protease inhibition assay 
 The protease inhibitory activity of the purified compound (compound 2) was determined as 
described previously (Kariu et al., 2017). Compounds exhibiting inhibitory activity to gingipains 
were identified by enzyme assays with t-butyloxycarbonyl-L-valyl-L-prolyl-L-arginine-4-
methylcoumaryl-7-amide (Boc-VPR-MCA) and t-butyloxycarbonyl-L-valyl‐L‐leucyl‐L‐lysine 
(Boc‐VLK‐MCA) as substrates for Rgp and Kgp, respectively. Ten microliters each of Pg-sup and 
compound 2 were added to mixtures containing 40 μL of 0.5 M Tris-HCl buffer (pH 7.6) and 30 
μL of distilled water containing 5 mM of L-cysteine. After 5-min preincubation at 37°C, 10 μL of 
500 μM Boc-VPR-MCA or Boc-VLK-MCA was added to the mixture. The release of 
aminomethyl-coumarin was measured by excitation at 380 nm and emission at 440 nm using a 
fluorescence spectrophotometer (Infinite M 200 Pro; Tecan Group, Ltd., Männedorf, Switzerland). 
The linear increase in aminomethyl-coumarin release was recorded for 10 min in the presence or 
absence of purified compound at different concentrations, and the half maximal inhibitory 
concentration (IC50) was calculated from the obtained dose-response curve.  
 
5.2.6 Minimum inhibitory concentration and half inhibitory concentration 
 The minimum inhibitory concentration (MIC) was calculated from the final concentration of 
the lowest dilution with complete inhibitory activity. For the minimum inhibitory concentration of 
the purified fractions, a 10 mg·mL-1 stock solution was prepared in methanol. For the 
hemagglutination assay, each fraction was diluted directly in a microplate with a round bottom 
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containing the hemagglutination assay reaction mixture to obtain a final concentration ranging 
from 0.5 to 0.016 mg·mL-1. The MIC was calculated from the lowest concentration of the fraction 
that completely inhibited hemagglutination activity. Each test was conducted in triplicate and the 
concentration required for 50% inhibition of viability (IC50) was determined. For the growth 
inhibition assay, the fractions were diluted in separate vials, then used in the reaction mixture.  
 
5.2.7 Isolation of biologically active compounds 
 Soluble compounds were extracted from about 200 g of dried and powdered leaves by soaking 
in 2.0 L distilled water twice for 30 min at room temperature with slow shaking. The soluble 
extracted compounds were collected by filtration, followed by centrifugation. The entire extract 
was partitioned between distilled water and ethyl acetate three times, yielding 3.24 g of ethyl 
acetate extract. The ethyl acetate extract was further fractionated by normal-phase chromatography. 
The column was packed with 162 g of silica gel powder (Wakogel C-300; Wako Pure Chemical 
Industries, Osaka, Japan) and eluted with acetone/hexane (0%–100%, v/v, 20% increments). The 
fraction eluted with 40% acetone (active fraction) yielded 1.65 g. This fraction was subjected to 
reversed phase chromatography with ODS gel (Cosmosil 75C18-OPN; Nacalai Tesque, Kyoto, 
Japan) eluted with methanol in water (0%–100%, v/v, 20% increments). The 80% methanol 
fraction (0.904 g) exhibited the highest inhibitory activity. HPLC fractionation of the 80% 
methanol fraction was performed under the following conditions: elution solvents, Milli-Q (A) and 
acetonitrile (B); gradient elution, 25%–100% B over 60 min; column, Cosmosil C18, (ø 20 ID × 
250 mm); flow rate, 7.0 mL·min-1; temperature, 40°C. The fractionation resulted in five sub-




5.2.8 Identification of biologically active compounds 
 All isolated compounds were tested to evaluate their inhibitory activity and the major compound 
was analyzed by 1H- and 13C NMR spectroscopy (Avance II; Bruker Billerica, MA). ESI MS 
analysis was performed with a mass spectrometer (Micromass Quattro; Waters, Milford, MA) 
combined with an ultra‐performance liquid chromatography system in positive mode. The mass 
range was m/z 200–800 and the column was an ACQUITY UPLC BEH C18 column (2.1 × 50 mm, 
1.7 μm; Waters). The solvents were acetonitrile containing 0.1% formic acid and Milli‐Q 
containing 0.1% formic acid with gradient elution from 5% to 100% for 10 min. The flow rate was 
0.2 mL·min-1 and the column temperature was 40°C. HRMS was recorded using an Exactive Mass 
Spectrometer (Thermo Fisher Scientific, Waltham, MA). 
 
5.3 Results 
5.3.1 Isolation of compound with inhibitory activity against the growth of P. gingivalis 
TDC60 
 We recently screened the aqueous extracts of a group of Sudanese medicinal plants for growth 
inhibition activity against P. gingivalis TDC60 strain by adding the extracts to GAM broth culture 
medium at a concentration of 1 mg·mL-1. The aqueous extract of dry leaves of S. argel totally 
inhibited the growth of this bacterial strain (Fig.5.1). Furthermore, analysis of inhibitory activity 
at different concentrations revealed that the aqueous extract of S. argel suppressed bacterial growth 
with a MIC of 0.5 mg·mL-1. We isolated the inhibitory compounds by extracting S. argel leaves 
with distilled water, followed by several purification steps, including liquid-liquid separation and 
column chromatography. Compounds in the active fraction were purified using HPLC. Five peaks 
were isolated, and the fractions were dried and weighed. The compounds were serially coded as 
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compounds 1, 2, 3, 4, and 5 (Fig.5.2). Compound 2 corresponded to the major peak (Fig.5.2) and 
was obtained in higher yield (70.6 mg) and inhibitory activity than the other fractions (Table 5.1).  
 
5.3.2 Structure determination 
 Compound 2 was a white amorphous powder. The 1H- and 13C-NMR data of this compound 
showed the presence of aglycone and sugars. The 1H NMR spectrum of the aglycone part is shown 
in Fig.5.3A and the assignments are given in Table 5.2. Signals were observed for three methyl 
groups at 1.03 (3H, s), 1.16 (3H, s), and 1.62 (3H, s), one olefinic proton at d 5.39 (1H, d, J = 3.0 
Hz), and one signal at 4.53 (1H, s) equivalent to a proton binding to a oxygenated carbon. 
Furthermore, the 13C NMR spectrum (Table 5.3 and Fig.5.3B) of the aglycone moiety proposed 
the presence of a pregnane skeleton providing twenty-one signals.  
 The 1H NMR spectrum for the sugar part showed four doublet signals corresponding to methyl 
groups at δH 1.39 (3H, d, J = 6.1 Hz), 1.29 (3H, d, J = 6.1 Hz), 1.25 (3H, d, J = 6.2 Hz) and 1.25 
(3H, d, J = 6.1 Hz), as well as three methoxy groups at δH 3.63 (3H, s), 3.45 (3H, s) and 3.42 (3H, 
s). In addition, four signals for anomeric protons were observed at δH 4.77 (1H, d, J = 9.6 Hz), 
4.69 (1H, d, J = 9.6 Hz), 4.61 (1H, d, J = 8.1 Hz) and 4.44 (1H, d, J = 7.8 Hz). These data 
demonstrated the presence of four sugars in compound 2. HR-ESI-MS of compound 2 (Fig.5.3C) 
(m/z 947.4954 [M + Na] +, calcd for C48H76O17Na, 947.4980) supported a molecular formula of 
C48H76O17. On the basis of the 
1H- and 13C-NMR and HR-ESI-MS data, we performed database 





canaropyranoside (Fig.5.2), which was previously isolated and identified from S. argel hairy seeds 
(Plaza et al., 2005). 
 
 




Table 5.1: Inhibition activities and yields of respective peaks on Fig.5.2 
Where: -: no inhibition activity was detected up to 500 μg·mL-1 






Gingipain inhibition IC50 (μg·mL-1)  
Rgp Kgp 
1 46.6 25 100 - - 
2 70.6 15 60 400 500 
3 24.1 100 - - - 
4 18.5 100 - - - 




Fig.5.2. Isolation and purification of argeloside I. The bottom panel shows the HPLC 
chromatogram of the 80% methanol fraction obtained by ODS column chromatography during the 
purification of argeloside I. The middle and top panels show the HPLC chromatogram of the 




Table 5.2: 1H NMR data (600 MHz, CD3OD) of 2 and argeloside I 
 
Position Compound 2 Argeloside Ia) 
 H, multi, J in Hz H, multi, J in Hz 
Sugars   
-D-Can   
1 4.69, d, J = 9.6 Hz 4.72 d, J = 9.2, 1.5 Hz 
6 1.25, d, J = 6.0 Hz 1.27, d, J = 6.1 Hz 
-D-Cym   
1 4.77, d, J = 9.6 Hz 4.80, dd, J = 9.6, 2.0 Hz 
6 1.25, d, J = 6.0 Hz 1.27, d, J = 6.1 Hz 
MeO 3.45 s 3.47, s 
-D-Ole   
1 4.61, d, J = 8.4 4.63, dd, J = 9.6, 2.0 Hz 
6 1.39, d, J = 6.1 Hz 1.40, d, J = 6.1 Hz 
MeO 3.42, s 3.45, s 
-D-The   
1 4.44, d, J = 7.8 Hz 4.46, d, J = 7.9 Hz 
6 1.29, d, J = 7.2 Hz 1.31, d, J = 6.1 Hz 
MeO 3.63, s 3.65, s 
Aglycone   
6 5.39, d, J = 3.0 Hz 5.43, dd, J = 3.3, 2.7 Hz 
16 4.53, s 4.56, br m 
17 2.49, d, J = 2.4 Hz 2.52, d, J = 2.2 Hz 
18 1.16, s 1.20, s  
19 1.03, s 1.06, s 














Table 5.3: 13C NMR data of 2 (150 MHz, CD3OD) and argeloside I  
 
δC of glycone part   δC of aglycone part  
2 
Argeloside I  
(Plaza et al., 2005) 
 
2 
Argeloside I  
(Plaza et al., 2005) 
104.3 104.3  141.1 141.3 
102.3 102.8  122.5 122.4 
100.6 100.7  114.9 114.8 
98.9 98.9  110.3 110.6 
88.8   89.1  79.3 79.0 
87.5 87.9  78.2 78.0 
83.9 84.3  71.7 71.9 
83.9 83.8  58.6 58.9 
80.2 80.2  50.0 49.9 
78.3 78.3  46.9 46.9 
76.7 76.5  39.8 39.6 
75.6 75..7  38.5 38.1 
73.2 72.9  37.1 37.3 
72.5 72.6  32.2 32.1 
71.7 71.8  30.9 30.9 
70.7 70.9  30.4 30.4 
70.4 70.5  25.8 25.6 
61.02 61.1  23.8 23.5 
58.8 58.7  20.8 20.4 
57.6 57.6  19.6 19.3 
40.0 40.2  15.5 15.5 
37.7 37.7    
36.4 36.4    
18.9 18.8    
18.2 18.3    
18.1 18.2    
18.1 18.1    
97 
 
5.3.3 Inhibitory characterization of argeloside I  
 The inhibitory activity of argeloside I against P. gingivalis growth was evaluated by measuring 
turbidity at 600 nm. The compounds greatly reduced cell proliferation and growth (Table 5.1) at a 
concentration of 10 μg·mL-1, and totally blocked cell growth and proliferation at 15 μg·mL-1 
(Fig.5.4A) with an IC50 value of 8.8 μg·mL
-1. Furthermore, we examined the inhibitory activity of 
argeloside I against P. gingivalis virulence factors in broth culture, and against exo-hemagglutinins 
and gingipains. This compound completely inhibited P. gingivalis exo-hemagglutinins, with a 
MIC value of 60 μg·mL-1 (Fig.5.4B). In addition, argeloside I suppressed Rgp activity, with an 
IC50 value of 400 μg·mL








Fig.5.3 Spectroscopic analyses of compound 2, which was subjected to 1H NMR (A), 13C NMR 





Fig.5.4 Inhibitory activity of argeloside I on P. gingivalis growth (A), hemagglutinins (B), and 
gingipains (C). A and B, P.G indicates P. gingivalis samples without argeloside I (negative control). 
C, each value represents the average of four independent experiments ± the standard deviation. 
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5.4 Discussion and conclusion 
 Porphyromonas gingivalis is an asaccharolytic bacterium that obtain nutrients and energy from 
the surrounding environment by adhering to host cells and degrading erythrocytes to extract iron 
as an essential nutrient in the very early stages of inflammation (Snipas et al., 2001; Shi et al., 
1999; Dashper et al., 2004). Hemagglutinins and gingipains are the main virulence factors of this 
pathogen and their activities are independent of bacterial cellular programs and cell viability 
(Snipas et al., 2001). Therefore, inhibition of these virulence factors and/or bacterial growth will 
obstruct bacterial adhesion to the host cells and might enable manipulation of the interaction 
between hemagglutinins and gingipains with erythrocyte proteins to hinder periodontitis 
development in the early stages (Miyachi et al., 2007; Yokoyama et al., 2007).   
 Numerous studies over the past several decades have targeted these virulent factors to inhibit 
the primary stages of periodontitis caused by P. gingivalis strains such as W83 and ATCC33277 
using natural therapeutic agents (Nakayama et al., 1996; Kadowaki et al., 1998). TDC60 strain 
was isolated from a patient with severe periodontal disease and displayed aggressive pathogenicity 
compared with W83, ATCC 33277, and other P. gingivalis strains (Watanabe et al., 2011). 
However, few studies have focused on the suppression of growth and virulence factors in TDC60. 
We therefore identified compounds in Sudanese medicinal plants that inhibit the growth of P. 
gingivalis TDC60 strain and its virulence factors (Eltigani et al., 2019). Of the tested plant extracts, 
only S. argel aqueous extract completely inhibited the growth of P. gingivalis TDC60 strain at a 
concentration of 1 mg·mL-1, and so in the present study, we aimed to isolate the agent responsible 
for this inhibiting activity.   
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 Solenostemma argel aqueous extract is reported to have antimicrobial, antifungal, and 
antibacterial properties against different pathogens and suppresses the growth of Aspergillus niger, 
Pennicilium italicum, Escherichia coli, and Salmonella typhi (Sulieman et al., 2009; Teia, 2018). 
However, to our knowledge, the present study is the first attempt to identify an inhibitor of the 
periodontal pathogen P. gingivalis and its virulence factors in an aqueous extract from S. argel 
leaves. We focused on water extracts since they are regularly consumed as herbal teas in Sudan 
and other African countries and are also used as folk remedies (Tharib et al., 2008; Taj Al- Deen 
et al., 2014). Compared with organic extracts, water extracts will have the potential to expand the 
conventional applications of this plant to functional foods, particularly in the rural communities.  
 The 1H NMR spectra of isolated compounds 1, 2, 3, 4 and 5 showed that they are pregnane 
glycosides although only the structure of 2 was determined. The isolated pregnane glycosides 
showed different levels of antibacterial activity against the periodontal pathogen P. gingivalis 
TDC60 and its pathogenicity factors (Table 5.1).  Compound 2 exhibited inhibition activity against 
the tested hemagglutinin and gingipain virulence factors. We therefore focused on the inhibitory 
activity of 2, previously identified and named argeloside I (Plaza et al., 2005).  
Argeloside I belongs to a large group of secondary metabolites known as pregnane glycosides. 
Pregnane glycosides are polar compounds consisting of combinations of steroidal aglycones and 
glycone parts of oligosaccharide chains arranged in a linear manner. The sugar chain is linked to 
the aglycon part through an acetal linkage to an aglycon hydroxy group (Panda et al., 2006). Recent 
studies have indicated a tremendous potential for medicinal applications of pregnanes because they 
exhibit anticancer activity and inhibit the proliferation of Kaposi's sarcoma cells (Plaza et al., 2005; 
Panda et al., 2006). 
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 The isolated pregnane glycosides exhibited inhibitory activity against P. gingivalis cells, with 
low MIC as shown in Fig.5.4. The inhibition by this type of compounds may be due to the aglycone 
part. A structure-activity relationship analysis by Liu (Liu et al., 2003) with different analogs 
suggested that the aglycone part of such compounds strongly influences activity. Another study 
reported that the degree of inhibition depends on the aglycone type of pregnane glycosides and the 
sequences of sugar moieties (Panda et al., 2006). However, the relationship between pregnane 
glycosides and the inhibition of P. gingivalis cell growth remains unclear. Further investigation 
using various pregnane glycosides with different sugar lengths is required to identify the 
importance of each part on the inhibition mechanism.   
 Porphyromonas gingivalis produces several extracellular virulence factors (Gharbia and Shah, 
1993; Okuda et al., 1986). These virulence factors include hemagglutinin and gingipains which 
are inhibited by argeloside I (Fig.5.4B and 5.4C). Hemagglutinin domains enable P. gingivalis to 
adhere to and colonize the tooth surface and/or the periodontal pocket to obtain heme by 
aggregating host erythrocytes, while gingipains provide nutrients for this bacterium to survive and 
proliferate. A recent study reported a strong correlation between Alzheimer’s disease and P. 
gingivalis via gingipains, which is promotes neuronal damage (Dominy et al., 2019). Dominy and 
colleagues found that gingipain immunoreactivity in the brain of Alzheimer’s disease patients was 
significantly greater than in non- Alzheimer’s disease control individuals, suggesting that 
gingipains are involved in Alzheimer’s disease in the early stage of brain infection by P. gingivalis 
(Dominy et al., 2019). Moreover, hemagglutinin is involved in P. gingivalis adhering to coronary 
artery endothelial cells, leading to cardiovascular disease (Lepine, and Progulske-Fox, 1996). The 
suppression of gingipain and hemagglutinin activity might also reduce the concentrations of 
peptide substrates and micro-nutrients available to P. gingivalis, hampering periodontitis 
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progression and potentially suppressing the development of other related diseases (Dominy et al., 
2019; Ingar and Potempa, 2014). Several studies have shown importance of inhibiting virulence 
factors for oral health but the total suppression of P. gingivalis growth has not been demonstrated. 
Thus, it is reasonable to assume the involvement of other proteins in the growth strategy of this 
bacterium (Blankenvoorde et al., 1998). Accordingly, the suppression of cell growth, 
hemagglutination, and gingipain activity by argeloside I should offer an opportunity to develop 
effective new inhibitors. Such combined inhibition might be due to the effect of argeloside I on 
cellular programs as well as reducing or influencing the production of virulence factors. 
 In conclusion, this report demonstrates that S. argel aqueous extract diminishes the proliferation 
of the TDC60, the most aggressive strain of P. gingivalis. Argeloside I was purified from the 
aqueous extract and shown to have anti-periodontitis activity by decreasing the growth of the 












 Periodontal diseases are a complex illness situation result from multi-microbial infections. P. 
gingivalis is among the pathogenic bacteria associated with the initiation of the gingival tissue 
inflammation, leading to the formulation of dental pockets, which form a suitable atmosphere for 
bacteria colonization, then the destruction of tooth-supporting tissues and finally loss of teeth. The 
primary stage of P. gingivalis inflammation initiates by adhesions to the host cells following by 
producing numerous virulence factors such as lipopolysaccharide, fimbriae, hemagglutinins, and 
several proteolytic enzymes. The proteolytic enzymes, which are known as gingipains and 
hemagglutinins, play a major role in P. gingivalis virulence since they are adherence factors that 
promote colonization and degrade host tissues. In addition, these enzymes may be crucial for 
providing heme and amino acids essential for the growth and proliferation of this asaccharolytic 
organism. The most recent strategies to inhibit periodontal disease by targeting the virulence 
factors of P. gingivalis in the early stages of the inflammation might hinder pathogenicity and 
improve the expansion of new, safe, effective therapeutic and preventative agents. 
 In the last decades, numerous plants and their natural products have been used around the world 
to treat several health disorders, including oral diseases. In Africa and particularly in Sudan, more 
than 80% of the population relies on traditional medicine to treat health problems for their 
abundance, safety, and fewer side effects. In this study, thirty-eight water extracts of selected plants 
used in Sudanese folkloric remedy were evaluated against P. gingivalis proliferation and its 
pathogenicity mediators. Several aqueous extracts exhibited a powerful role in blocking the very 
early stages of P. gingvalis virulence-related factors. Many studies reported that it is a challenging 
and complicated to impede all the virulence-related factors of P. gingivalis. 
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 Nonetheless, the extract of O. vulgare leaves revealed multi-inhibition effects on the tested 
assays. The hydrolysable tannin from O. vulgare leaves showed a broad spectrum, impeding the 
targeted virulence-related factors. On the other hand, the isolated compounds from M. ciliatum 
seeds had a specific effect on the hemagglutinins of P. gingivalis. Coumarin, oleic acid, and its 
esters were the leading compounds against hemagglutinins. Since oleic acid revealed the lowest 
MIC value compared with other isolates, we subsequently compared the influence of saturated and 
non-saturated fatty acids with middle and long carbon chains against P. gingivalis and 
hemagglutinins. The long-chain unsaturated fatty acids exhibited high inhibitory activity 
compared to that of saturated fatty acids. Additionally, sub-MIC dosages of unsaturated fatty acids 
suppressed secretion of hemagglutinin and gingipains of P. gingivalis TDC60. In contrast, S. argel 
leaves aqueous extract had the most substantial influence on P. gingivalis growth since it 
diminished the proliferation of the most aggressive strain of P. gingivalis (TDC60 strain). 
Argeloside I purified from the aqueous extract of leaves were found to have anti- hemagglutinins 
and anti- gingipains activities besides its capability to suppress the growth of P. gingivalis. 
 Most of the selected medicinal plants in this study have been continuously used in folkloric 
medicine and as spices in daily cooking, which reflect their safety consumption. The pleasant 
aroma and pharmaceutically bioactive compounds of O. vulgare leaves and M. ciliatum seeds have 
received increasing attention as potent sources for the reformation of different foods and 
pharmaceutical products. Additionally, isolated hydrolysable tannins from O. vulgare leaves have 
a high polarity and water solubility, this feature might provide a suitable condition in the 
manufacturing applications as oral hygiene agents or functional food additives. Unsaturated fatty 
acids revealed a good influence on P. gingivalis and its virulence besides its nutritional roles. These 
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fatty acids found abundantly in natural products. Therefore, it is safe additive agents, especially 
with the low MIC values level required for the inhibition process. 
 Moreover, S. argel leaves aqueous extract is one of the popular drinks in many Arabic and 
African countries, including Sudan. It’s believed to have superior effects against different health 
problems. However, anti- p. gingivalis pathogenicity function of the isolated compound 
(argeloside I) seems to be new. This function believed to be a starting point for expanding the use 
of S. argel extract and argeloside I. Overall, several compounds with potent influences on P. 
gingivalis pathogenicity were isolated and identified in the current dissertation, but their mode of 









1H NMR of compound 8A 
 
Fig.S1 the 1H NMR spectrum of compound 8A (600 MHz, CDCl3), which isolated from the 









13C NMR of compound 8A 
 
Fig.S2 the 13C NMR spectrum of compound 8A (150 MHz, CDCl3), isolated from the aqueous 








1H NMR of compound 8C 
 
Fig.S3 the 1H NMR spectrum of compound 8C at 600 MHz using CDCl3solvent. Compound 8C 









13C NMR of compound 8C 
 
Fig.S4 the 13C NMR spectrum of compound 8C at 150 MHz using CDCl3solvent. Compound 8C 










1H NMR of compound B4  
 
Fig.S5 the 1H NMR spectrum of compound B4, which isolated from Monechma ciliatum seed’s 









1H NMR of compound B5 
 
Fig.S6 the 1H NMR spectrum of compound B5, which isolated from Monechma ciliatum seed’s 









1H NMR of compound 2 
 
Fig.S7 1H NMR spectrum of compound 2 isolated from aqueous extract of Solenostemma argel 









13C NMR of compound 2 
 
Fig.S7 13C NMR spectrum of compound 2 isolated from aqueous extract of Solenostemma argel 
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 Oral illnesses are one of the critical chronic diseases. Of them, periodontal disease 
(periodontitis) is a major oral health problem, caused by bacterial inflammation of the tissues 
supporting the teeth. Numerous diverse bacteria exist simultaneously in the oral cavities of patients 
with periodontal disease. Mainly, Porphyromonas gingivalis, a gram-negative, asaccharolytic, 
obligate anaerobic rod bacterium, appears to be the prime etiological agent associated with the 
progression of the inflammatory events underlying periodontal disease. P. gingivalis produces 
several virulence factors in the outer cell membrane. The primary stage of bacterial pathogenesis 
begins with the adhesion of bacterial cells to host tissues followed by colonization, which provides 
nutrients and allows bacteria to survive, grow, and produce further virulence factors. These 
virulence agents include numerous molecules associated with adherence and colonization, such as 
fimbriae, lipopolysaccharides, proteases like gingipains, and hemagglutinins. The most important 
virulence factors that P. gingivalis produces are the hemagglutinins and gingipains, which play a 
vital role in the infection process through facilitating adhere of P. gingivalis to the surface of host 
cells following by acquisition of heme through erythrocyte binding and causes lysis and 
aggregation of erythrocytes via several proteolytic enzymes to release the heme moiety from the 
hemoglobin molecule as a nutrient.  
  The development of anti-adhesive agents against P. gingivalis hemagglutinins and gingipains 
could be a promising cytoprotective strategy to prevent the harmful effects of long-term bacterial 
infection. Over the past few years, several plants derived natural products have been described for 
oral disease treatment and as adjuvant remedies that aim to reduce inflammation through 
interaction with the adhesion of P. gingivalis to host cells. In this study, we aimed to screen a 
group of Sudanese medicinal plants that are used traditionally in the Sudanese folkloric medicine 
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against P. gingivalis TDC60 proliferation and virulence factors. Consequently, thirty-eight organ 
parts from twenty-five plant species were collected from Khartoum state, Sudan (The voucher 
specimens were prepared and identified at the faculty of agriculture and faculty of forest, university 
of Khartoum, Khartoum, Sudan) to investigate the potential inhibitory activities of their aqueous 
extracts. Thereafter, the research aimed to isolate, purify and identify the biologically active 
compounds of the most active plants extract on P. gingivalis proliferation and specific virulence 
factor/s.  
 The thesis consists of five chapters. Chapter one is a general introduction, research objectives, 
and thesis outlines. In chapter two, details of non-specific inhibitor isolated from Origanum 
vulgare leaves restrains P. gingivalis TDC60 growth and virulence factors. Chapter three focuses 
on isolates from Monechma ciliatum seeds' extract that hampered P. gingivalis TDC60 
hemagglutinins, while chapter four demonstrated the influence of long-chain fatty acids using sub-
MICs model against P. gingivalis TDC60 pathogenicity. Finally, chapter five shows argeloside I, 
from Solenostemma argel leaves, a candidate hostile to the pathogenicity of P. gingivalis TDC60. 
 Primarily, the crude aqueous extracts from 38 plant organs of 25 plant species were screened to 
inhibit hemolysis, hemagglutination, gingipains, and bacterial growth, as illustrated in chapter two. 
Although several plants inactivated virulence factors (hemolysis, hemagglutination, and 
gingipains) independent of cell growth suppression, only three plants, namely O. vulgare (leaves), 
Glycyrrhiza glabra (areal parts) and Salvia offinalis (areal parts) hindered cell growth and 
virulence agents of P. gingivalis. Among them, the aqueous extract of O. vulgare provided low 
MIC values for heme aggregation, erythrocyte lysis, and gingipain. The inhibitory compound from 
O. vulgare leaves was isolated and characterized as a hydrolysable tannin-like compound that non-
specifically suppressed P. gingivalis proliferation and virulence factors. Hydrolysable tannin-like 
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compound was characterized against tannic acid using HPLC, Prussian blue staining, and MALDI-
TOF MS. The isolated compound inhibited the cell growth with a MIC of 0.05 mg.mL-1 and 
gingipains (IC50 = 0.05 mg.mL-1) as well as heme aggregation and erythrocyte lysis with a MIC 
of 0.0063 mg.mL-1 for both virulence’s. 
 The third chapter works were focused on the potent hemagglutinin inhibition found from M. 
cilliatum aqueous extract. Hemagglutinins are vital molecules, allow P. gingivalis to uptake iron 
and heme by attaching, aggregating, and lysing erythrocytes. To isolate and identify the inhibitory 
compounds, the water extracted from dry powdered seeds of M. ciliatum was partitioned using 
ethyl acetate followed by reversed‐phase chromatography, thin‐layer chromatography, ESI‐MS, 
and NMR analysis resulting in the isolation of four compounds identified as oleic acid, coumarin, 
1,2‐dioleoylglycerol, and 1,3‐dioleoylglycerol with MICs of 15–100 μg.mL-1 against 
hemagglutination. This evidence of inhibitory activity will encourage the application of M. 
ciliatum effectively either as a functional food or therapeutic agent. Subsequently, in chapter four, 
we extended our study to compare the influence of long-chain fatty acids on hemagglutinins in 
correlation to P. gingivais growth and gingipains. Ten fatty acids with different saturation degrees 
and carbon chain length were selected for the first screening against P. gingivalis growth and 
hemagglutinins activity. Of them, unsaturated fatty acids showed lower MIC values compared to 
that of saturated fatty acids. Five unsaturated fatty acids were selected for further analysis using 
sub-minimum inhibitory concentration (sub-MIC) model against P. gingivalis growth, 
hemagglutination activity, and gingipains. The results showed that the sub-MICs dosages of 
unsaturated fatty acids significantly affected P. gingivalis growth and hemagglutinins and 
gingipain secretion. The N-terminal analysis of partially purified protein revealed that six protein 
bands corresponding to gingipain R1 hemagglutinin, lysine gingipain, and hemagglutinin genes 
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decreased inversely with the sub-MICs concentrations of unsaturated fatty acids. This section's 
results might support and expand the uses of the fatty acids as safe additives to impede undesired 
microbes to prevent periodontal diseases in the early stages.  
 The study in chapter five was focused on the isolation, purification, and identification of the 
most inhibitory compound in the aqueous extract of S. argel leaves that reveal the most potent 
inhibition activity against P. gingivalis proliferation among all test plants. We isolated and 
identified the inhibitory compounds by extracting S. argel leaves with distilled water, followed by 
several purification steps, including liquid-liquid separation, column chromatography, 1H- and 
13C-NMR, and HR-ESI-MS resulting in a known pregnane glycoside, named as argeloside I.  
Argeloside I hindered cell growth of P. gingivalis TDC60 at 15 μg.mL-1 and inhibited the 
hemagglutinins with a MIC value of 60 μg.mL-1, as well as Arg and Lys specific gingipains with 
IC50 of 400 and 500 μg.mL-1, respectively. The results show a new function for the pregnane 
glycosides, and argeloside I might be a preventing agent candidate for reducing the risk of P. 
gingivalis TDC60 and adhesion factors. 
 In conclusion, the current dissertation demonstrated the inhibitory activities of selected plants 
used traditionally in Sudanese folkloric medicine against P. gingivalis pathogenicity. Several 
compounds were introduced to the scientific community as candidates to hostile P. gingivalis 
and/or its virulence factors, including oleic acid, coumarin, 1,2‐dioleoylglycerol, and 1,3‐


























 本論文は 5つの章で構成され、第 1章は本研究の背景、目的、及び概要を示す。第 2章で
は、香辛料等としても利用される Origanum vulgareの葉から抽出された P. gingivalisTDC60株
の増殖や分泌される病原性因子の非特異的阻害物質について、第 3 章では、Monechma 
ciliatum の種子に由来する赤血球凝集素の阻害物質について、第 4 章では P. 
gingivalisTDC60 株の病原性に対するサブ MIC モデルを使用した、長鎖脂肪酸の阻害効果に
ついて、第 5章では、ハーブ Solenostemma argelの葉の水抽出物から単離されたアルゲロシド
I とその P. gingivalisTDC60 株の増殖や病原性に対する効果について述べる。 
 本研究は、38 サンプルの植物の器官（25 種の植物）の水粗抽出物のスクリーニングから始
まる。これらの抽出物について、P. gingivalis TDC60 株が生産する溶血素、赤血球凝集素、ジ
ンジパインの阻害効果、そして菌の増殖抑制効果を評価した。その結果、O. vlugare の葉、
Glycyrrhiza glabraの表皮部、Salvia offinalisの表皮部で、P. gingivalis TDC60の増殖と病原因
子を共に抑制した。中でも O. vlugare の葉の水抽出物は病原因子に対する MIC 値が最も低
く、その阻害物質を単離し、HPLC、プルシアンブルー染色、MALDI-TOF MS解析を行った結
果、加水分解性タンニン様化合物であることが明らかとなった。本化合物の P. gingivalis 
TDC60の増殖に対する MICは 0.05 mg·mL-1、ジンジパインに対する IC50は 0.05 mg·mL
-1、赤
血球凝集素と溶血素に対する MICは 0.0063 mg·mL-1であった。 
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 第 3章では、M. cilliatumの水抽出物から単離された強力な赤血球凝集素の阻害物質に焦
点を当てた。赤血球凝集素は歯周病の疾病や重症化に主要な働きをする物質であり、本物質
により P. gingivalis が赤血球を凝集し、溶解してヘムを獲得する。阻害物質の単離では、種子
の乾燥粉末の水粗抽出物から溶媒抽出、逆相クロマトグラフィー、薄層クロマトグラフィーを行 4
つの化合物を単離し、その後 ESI-MS 及び NMR によりそれらの同定を行った。その結果、4 つ
の化合物はオレイン酸、クマリン、1,2-ジオレイルグリセロール、1,3-ジオレイルグリセロールと
同定され、それぞれの赤血球凝集素に対する MICは 15～100 µg·mL-1であった。 
 続いて、第 4 章では、P. gingivalis TDC60 株の生育、ジンジパイン活性、赤血球凝集素活
性の阻害に対する長鎖脂肪酸構造との関連について調べた。オレイン酸の構造を軸として、飽
和度や炭素鎖長が異なる 10種類の脂肪酸を選抜し、阻害の強さとの比較を行った結果、不飽
和脂肪酸は飽和脂肪酸に比べて MIC 値は低い結果となった。さらに 5 つの不飽和脂肪酸を
選抜し、P. gingivalis TDC60株の増殖と病原性因子に対するサブ MICを分析した結果、不飽
和脂肪酸の処理は、P. gingivalis TDC60株の増殖に加え、ジンジパインや赤血球凝集素の分
泌にも大きな影響を与えた。 
 第 5章では、P. gingivalis TDC60株の増殖に対して最も強力な阻害活性を示したハーブ S. 
argel の葉の水抽出物に焦点を当て、阻害物質の単離と同定を行った。S. argel の葉の水抽出
物から溶媒抽出、順相クロマトグラフィーを行って阻害物質を単離し、1H-NMR、13C-NMR、
HR-ESI-MSを行って阻害物質を同定した。同定された物質アルゲロシド Iは、MIC値が 15 µg
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